[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6344 Enrolled Bill (ENR)]


        H.R.6344

                       One Hundred Ninth Congress

                                 of the

                        United States of America


                          AT THE SECOND SESSION

          Begun and held at the City of Washington on Tuesday,
             the third day of January, two thousand and six


                                 An Act


 
     To reauthorize the Office of National Drug Control Policy Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF CONTENTS.
    (a) Short Title.--This Act may be cited as the ``Office of National 
Drug Control Policy Reauthorization Act of 2006''.
    (b) Amendment of Office of National Drug Control Policy 
Reauthorization Act of 1998.--Except as otherwise expressly provided, 
whenever in this Act an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, the reference 
shall be considered to be made to a section or other provision of the 
Office of National Drug Control Policy Reauthorization Act of 1998 
(Public Law 105-277; 21 U.S.C. 1701 et seq.).
    (c) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title, reference, and table of contents.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

Sec. 101. Amendments to definitions.
Sec. 102. Establishment of the Office of National Drug Control Policy.
Sec. 103. Appointment and responsibilities of the Director.
Sec. 104. Amendments to ensure coordination with other agencies.
Sec. 105. Budgetary matters.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

Sec. 201. Annual preparation and submission of National Drug Control 
          Strategy.
Sec. 202. Performance measurements.
Sec. 203. Annual report requirement.

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

Sec. 301. High Intensity Drug Trafficking Areas Program.
Sec. 302. Funding for certain high intensity drug trafficking areas.
Sec. 303. Assessment.

                          TITLE IV--TECHNOLOGY

Sec. 401. Counterdrug Technology Assessment Center.

                 TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN

Sec. 501. National Youth Anti-Drug Media Campaign.

       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

Sec. 601. Authorization of appropriations.
Sec. 602. Extension of termination date.

                      TITLE VII--ANTI-DOPING AGENCY

Sec. 701. Designation of United States Anti-Doping Agency.
Sec. 702. Records, audit, and report.
Sec. 703. Authorization of appropriations.

                    TITLE VIII--DRUG-FREE COMMUNITIES

Sec. 801. Reauthorization.
Sec. 802. Suspension of grants.
Sec. 803. Grant award increase.
Sec. 804. Prohibition on additional eligibility criteria.
Sec. 805. National Community Anti-Drug Coalition Institute.

              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

Sec. 901. National Guard counterdrug schools.

 TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006

Sec. 1001. Short title.
Sec. 1002. Definitions.
Sec. 1003. Establishment of clearinghouse and advisory council.
Sec. 1004. NMIC requirements and review.
Sec. 1005. Authorization of appropriations.

                   TITLE XI--MISCELLANEOUS PROVISIONS

Sec. 1101. Repeals.
Sec. 1102. Controlled Substances Act amendments.
Sec. 1103. Report on law enforcement intelligence sharing.
Sec. 1104. Requirement for South American heroin strategy.
Sec. 1105. Model acts.
Sec. 1106. Study on iatrogenic addiction associated with prescription 
          opioid analgesic drugs.
Sec. 1107. Requirement for strategy to stop Internet advertising of 
          prescription medicines without a prescription.
Sec. 1108. Requirement for study on diversion and inappropriate uses of 
          prescription drugs.
Sec. 1109. Requirement for Afghan Heroin Strategy.
Sec. 1110. Requirement for Southwest Border Counternarcotics Strategy.
Sec. 1111. Requirement for Scientific Study of Mycoherbicide in Illicit 
          Drug Crop Eradication.
Sec. 1112. Requirement for Study of State Precursor Chemical Control 
          Laws.
Sec. 1113. Requirement for Study of Drug Endangered Children Programs.
Sec. 1114. Study on drug court hearings in nontraditional places.
Sec. 1115. Report on tribal Government participation in HIDTA process.
Sec. 1116. Report on school drug testing.
Sec. 1117. Report on ONDCP performance bonuses.
Sec. 1118. Requirement for disclosure of Federal sponsorship of all 
          Federal advertising or other communication materials.
Sec. 1119. Awards for demonstration programs by local partnerships to 
          coerce abstinence in chronic hard-drug users under community 
          supervision through the use of drug testing and sanctions.
Sec. 1120. Policy relating to syringe exchange programs.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

    SEC. 101. AMENDMENTS TO DEFINITIONS.
    (a) Demand Reduction.--Section 702(1) is amended--
        (1) in subparagraph (F), by striking ``and'' after the 
    semicolon;
        (2) in paragraph (G), by striking the period at the end and 
    inserting ``, including the testing of employees;''; and
        (3) by adding at the end the following:
            ``(H) interventions for drug abuse and dependence;
            ``(I) international drug control coordination and 
        cooperation with respect to activities described in this 
        paragraph; and
            ``(J) international drug abuse education, prevention, 
        treatment, research, rehabilitation activities, and 
        interventions for drug abuse and dependence.''.
    (b) National Drug Control Program.--Section 702(6) is amended by 
adding before the period the following: ``, including any activities 
involving supply reduction, demand reduction, or State, local, and 
tribal affairs''.
    (c) Program Change.--Section 702(7) is amended by--
        (1) striking ``National Foreign Intelligence Program,'' and 
    inserting ``National Intelligence Program,''; and
        (2) inserting after ``Related Activities,'' the following: ``or 
    (for purposes of section 704(d)) an agency that is described in 
    section 530C(a) of title 28, United States Code,''.
    (d) Office.--Section 702(9) is amended by striking ``implicates'' 
and inserting ``indicates''.
    (e) State, Local, and Tribal Affairs.--Paragraph (10) of section 
702 is amended to read as follows:
        ``(10) State, local, and tribal affairs.--The term `State, 
    local, and tribal affairs' means domestic activities conducted by a 
    National Drug Control Program agency that are intended to reduce 
    the availability and use of illegal drugs, including--
            ``(A) coordination and enhancement of Federal, State, 
        local, and tribal law enforcement drug control efforts;
            ``(B) coordination and enhancement of efforts among 
        National Drug Control Program agencies and State, local, and 
        tribal demand reduction and supply reduction agencies;
            ``(C) coordination and enhancement of Federal, State, 
        local, and tribal law enforcement initiatives to gather, 
        analyze, and disseminate information and law enforcement 
        intelligence relating to drug control among domestic law 
        enforcement agencies; and
            ``(D) other coordinated and joint initiatives among 
        Federal, State, local, and tribal agencies to promote 
        comprehensive drug control strategies designed to reduce the 
        demand for, and the availability of, illegal drugs.''.
    (f) Supply Reduction.--Section 702(11) is amended to read as 
follows:
        ``(11) Supply reduction.--The term `supply reduction' means any 
    activity or program conducted by a National Drug Control Program 
    agency that is intended to reduce the availability or use of 
    illegal drugs in the United States or abroad, including--
            ``(A) law enforcement outside the United States;
            ``(B) source country programs, including economic 
        development programs primarily intended to reduce the 
        production or trafficking of illicit drugs;
            ``(C) activities to control international trafficking in, 
        and availability of, illegal drugs, including--
                ``(i) accurate assessment and monitoring of 
            international drug production and interdiction programs and 
            policies; and
                ``(ii) coordination and promotion of compliance with 
            international treaties relating to the production, 
            transportation, or interdiction of illegal drugs;
            ``(D) activities to conduct and promote international law 
        enforcement programs and policies to reduce the supply of 
        drugs; and
            ``(E) activities to facilitate and enhance the sharing of 
        domestic and foreign intelligence information among National 
        Drug Control Program agencies, relating to the production and 
        trafficking of drugs in the United States and in foreign 
        countries.''.
    (g) Definitions of Appropriate Congressional Committees and Law 
Enforcement.--Section 702 is amended by adding at the end the 
following:
        ``(12) Appropriate congressional committees.--Except where 
    otherwise provided, the term `appropriate congressional committees' 
    means the Committee on the Judiciary, the Committee on 
    Appropriations, and the Caucus on International Narcotics Control 
    of the Senate and the Committee on Government Reform, the Committee 
    on the Judiciary, and the Committee on Appropriations of the House 
    of Representatives.
        ``(13) Law enforcement.--The term `law enforcement' or `drug 
    law enforcement' means all efforts by a Federal, State, local, or 
    tribal government agency to enforce the drug laws of the United 
    States or any State, including investigation, arrest, prosecution, 
    and incarceration or other punishments or penalties.''.
    SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL DRUG CONTROL 
      POLICY.
    (a) Responsibilities.--Section 703(a) is amended to read as 
follows:
    ``(a) Establishment of Office.--There is established in the 
Executive Office of the President an Office of National Drug Control 
Policy, which shall--
        ``(1) develop national drug control policy;
        ``(2) coordinate and oversee the implementation of the national 
    drug control policy;
        ``(3) assess and certify the adequacy of National Drug Control 
    Programs and the budget for those programs; and
        ``(4) evaluate the effectiveness of the national drug control 
    policy and the National Drug Control Program agencies' programs, by 
    developing and applying specific goals and performance 
    measurements.''.
    (b) Positions.--Section 703(b) is amended to read as follows:
    ``(b) Director of National Drug Control Policy and Deputy 
Directors.--
        ``(1) Director.--There shall be a Director of National Drug 
    Control Policy who shall head the Office (referred to in this Act 
    as the `Director') and shall hold the same rank and status as the 
    head of an executive department listed in section 101 of title 5, 
    United States Code.
        ``(2) Deputy director.--There shall be a Deputy Director of 
    National Drug Control Policy who shall report directly to the 
    Director (referred to in this Act as the `Deputy Director').
        ``(3) Other deputy directors.--
            ``(A) In general.--There shall be a Deputy Director for 
        Demand Reduction, a Deputy Director for Supply Reduction, and a 
        Deputy Director for State, Local, and Tribal Affairs.
            ``(B) Reporting.--The Deputy Director for Demand Reduction, 
        the Deputy Director for Supply Reduction, and the Deputy 
        Director for State, Local, and Tribal Affairs shall report 
        directly to the Deputy Director of the Office of National Drug 
        Control Policy.
            ``(C) Deputy director for demand reduction.--The Deputy 
        Director for Demand Reduction shall be responsible for the 
        activities in subparagraphs (A) through (H) of section 702(l).
            ``(D) Deputy director for supply reduction.--The Deputy 
        Director for Supply Reduction shall--
                ``(i) have substantial experience and expertise in drug 
            interdiction and other supply reduction activities; and
                ``(ii) be responsible for the activities in 
            subparagraphs (A) through (C) in section 702(11).
            ``(E) Deputy director for state, local, and tribal 
        affairs.--The Deputy Director for State, Local, and Tribal 
        Affairs shall be responsible for the activities--
                ``(i) in subparagraphs (A) through (D) of section 
            702(10);
                ``(ii) in section 707, the High Intensity Drug 
            Trafficking Areas Program; and
                ``(iii) in section 708, the Counterdrug Technology 
            Assessment Center.''.
    SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE DIRECTOR.
    (a) Succession.--Section 704(a) is amended by amending paragraph 
(3) to read as follows:
        ``(3) Acting director.--If the Director dies, resigns, or is 
    otherwise unable to perform the functions and duties of the office, 
    the Deputy Director shall perform the functions and duties of the 
    Director temporarily in an acting capacity pursuant to subchapter 
    III of chapter 33 of title 5, United States Code.''.
    (b) Responsibilities.--Section 704(b) is amended--
        (1) in paragraph (4), by striking ``Federal departments and 
    agencies engaged in drug enforcement'' and inserting ``National 
    Drug Control Program agencies'';
        (2) in paragraph (7), by inserting after ``President'' the 
    following: ``and the appropriate congressional committees'';
        (3) in paragraph (13), by striking ``(beginning in 1999)'';
        (4) by striking paragraph (14) and inserting the following:
        ``(14) shall submit to the appropriate congressional committees 
    on an annual basis, not later than 60 days after the date of the 
    last day of the applicable period, a summary of--
            ``(A) each of the evaluations received by the Director 
        under paragraph (13); and
            ``(B) the progress of each National Drug Control Program 
        agency toward the drug control program goals of the agency 
        using the performance measures for the agency developed under 
        section 706(c);'';
        (5) in paragraph (15), by striking subparagraph (C) and 
    inserting the following:
            ``(C) supporting the substance abuse information 
        clearinghouse administered by the Administrator of the 
        Substance Abuse and Mental Health Services Administration and 
        established in section 501(d)(16) of the Public Health Service 
        Act by--
                ``(i) encouraging all National Drug Control Program 
            agencies to provide all appropriate and relevant 
            information; and
                ``(ii) supporting the dissemination of information to 
            all interested entities;''; and
        (6) by inserting at the end the following:
        ``(16) shall coordinate with the private sector to promote 
    private research and development of medications to treat addiction;
        ``(17) shall seek the support and commitment of State, local, 
    and tribal officials in the formulation and implementation of the 
    National Drug Control Strategy;
        ``(18) shall monitor and evaluate the allocation of resources 
    among Federal law enforcement agencies in response to significant 
    local and regional drug trafficking and production threats;
        ``(19) shall submit an annual report to Congress detailing how 
    the Office of National Drug Control Policy has consulted with and 
    assisted State, local, and tribal governments with respect to the 
    formulation and implementation of the National Drug Control 
    Strategy and other relevant issues; and
        ``(20) shall, within 1 year after the date of the enactment of 
    the Office of National Drug Control Policy Reauthorization Act of 
    2006, report to Congress on the impact of each Federal drug 
    reduction strategy upon the availability, addiction rate, use rate, 
    and other harms of illegal drugs.''.
    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
        (1) in subparagraph (C)(iii), by inserting ``and the 
    appropriate congressional committees,'' after ``House of 
    Representatives''; and
        (2) in subparagraph (D)(ii)(II)(bb), by inserting ``and the 
    appropriate congressional committees,'' after ``House of 
    Representatives''.
    (d) Powers of Director.--Section 704(d) is amended--
        (1) in paragraph (9), by striking ``Strategy; and'' and 
    inserting ``Strategy and notify the appropriate congressional 
    committees of any fund control notice issued in accordance with 
    section 704(f)(5);''; and
        (2) in paragraph (10), by inserting before the period the 
    following: ``and section 706 of the Department of State 
    Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j-1)''.
    (e) Fund Control Notices.--Section 704(f) is amended by adding at 
the end the following:
        ``(4) Congressional notice.--A copy of each fund control notice 
    shall be transmitted to the appropriate congressional committees.
        ``(5) Restrictions.--The Director shall not issue a fund 
    control notice to direct that all or part of an amount appropriated 
    to the National Drug Control Program agency account be obligated, 
    modified, or altered in any manner--
            ``(A) contrary, in whole or in part, to a specific 
        appropriation; or
            ``(B) contrary, in whole or in part, to the expressed 
        intent of Congress.''.
    (f) Drug Interdiction.--
        (1) In general.--Section 711 is amended by adding at the end 
    the following:
    ``SEC. 711. DRUG INTERDICTION COORDINATOR AND COMMITTEE.
    ``(a) United States Interdiction Coordinator.--
        ``(1) In general.--The United States Interdiction Coordinator 
    shall perform the duties of that position described in paragraph 
    (2) and such other duties as may be determined by the Director with 
    respect to coordination of efforts to interdict illicit drugs from 
    entering the United States.
        ``(2) Responsibilities.--The United States Interdiction 
    Coordinator shall be responsible to the Director for--
            ``(A) coordinating the interdiction activities of the 
        National Drug Control Program agencies to ensure consistency 
        with the National Drug Control Strategy;
            ``(B) on behalf of the Director, developing and issuing, on 
        or before March 1 of each year and in accordance with paragraph 
        (3), a National Interdiction Command and Control Plan to ensure 
        the coordination and consistency described in subparagraph (A);
            ``(C) assessing the sufficiency of assets committed to 
        illicit drug interdiction by the relevant National Drug Control 
        Program agencies; and
            ``(D) advising the Director on the efforts of each National 
        Drug Control Program agency to implement the National 
        Interdiction Command and Control Plan.
        ``(3) Staff.--The Director shall assign such permanent staff of 
    the Office as he considers appropriate to assist the United States 
    Interdiction Coordinator to carry out the responsibilities 
    described in paragraph (2), and may also, at his discretion, 
    request that appropriate National Drug Control Program agencies 
    detail or assign staff to the Office of Supply Reduction for that 
    purpose.
        ``(4) National interdiction command and control plan.--
            ``(A) Purposes.--The National Interdiction Command and 
        Control Plan shall--
                ``(i) set forth the Government's strategy for drug 
            interdiction;
                ``(ii) state the specific roles and responsibilities of 
            the relevant National Drug Control Program agencies for 
            implementing that strategy; and
                ``(iii) identify the specific resources required to 
            enable the relevant National Drug Control Program agencies 
            to implement that strategy.
            ``(B) Consultation with other agencies.--The United States 
        Interdiction Coordinator shall issue the National Interdiction 
        Command and Control Plan in consultation with the other members 
        of the Interdiction Committee described in subsection (b).
            ``(C) Limitation.--The National Interdiction Command and 
        Control Plan shall not change existing agency authorities or 
        the laws governing interagency relationships, but may include 
        recommendations about changes to such authorities or laws.
            ``(D) Report to congress.--On or before March 1 of each 
        year, the United States Interdiction Coordinator shall provide 
        a report on behalf of the Director to the appropriate 
        congressional committees, to the Committee on Armed Services 
        and the Committee on Homeland Security of the House of 
        Representatives, and to the Committee on Homeland Security and 
        Governmental Affairs and the Committee on Armed Services of the 
        Senate, which shall include--
                ``(i) a copy of that year's National Interdiction 
            Command and Control Plan;
                ``(ii) information for the previous 10 years regarding 
            the number and type of seizures of drugs by each National 
            Drug Control Program agency conducting drug interdiction 
            activities, as well as statistical information on the 
            geographic areas of such seizures; and
                ``(iii) information for the previous 10 years regarding 
            the number of air and maritime patrol hours undertaken by 
            each National Drug Control Program agency conducting drug 
            interdiction activities, as well as statistical information 
            on the geographic areas in which such patrol hours took 
            place.
            ``(E) Treatment of classified or law enforcement sensitive 
        information.--Any content of the report described in 
        subparagraph (D) that involves information classified under 
        criteria established by an Executive order, or the public 
        disclosure of which, as determined by the Director, the 
        Director of National Intelligence, or the head of any Federal 
        Government agency the activities of which are described in the 
        plan, would be detrimental to the law enforcement or national 
        security activities of any Federal, State, or local agency, 
        shall be presented to Congress separately from the rest of the 
        report.
    ``(b) Interdiction Committee.--
        ``(1) In general.--The Interdiction Committee shall meet to--
            ``(A) discuss and resolve issues related to the 
        coordination, oversight and integration of international, 
        border, and domestic drug interdiction efforts in support of 
        the National Drug Control Strategy;
            ``(B) review the annual National Interdiction Command and 
        Control Plan, and provide advice to the Director and the United 
        States Interdiction Coordinator concerning that plan; and
            ``(C) provide such other advice to the Director concerning 
        drug interdiction strategy and policies as the committee 
        determines is appropriate.
        ``(2) Chairman.--The Director shall designate one of the 
    members of the Interdiction Committee to serve as chairman.
        ``(3) Meetings.--The members of the Interdiction Committee 
    shall meet, in person and not through any delegate or 
    representative, at least once per calendar year, prior to March 1. 
    At the call of either the Director or the current chairman, the 
    Interdiction Committee may hold additional meetings, which shall be 
    attended by the members either in person, or through such delegates 
    or representatives as they may choose.
        ``(4) Report.--Not later than September 30 of each year, the 
    chairman of the Interdiction Committee shall submit a report to the 
    Director and to the appropriate congressional committees describing 
    the results of the meetings and any significant findings of the 
    Committee during the previous 12 months. Any content of such a 
    report that involves information classified under criteria 
    established by an Executive order, or whose public disclosure, as 
    determined by the Director, the chairman, or any member, would be 
    detrimental to the law enforcement or national security activities 
    of any Federal, State, local, or tribal agency, shall be presented 
    to Congress separately from the rest of the report.''.
        (2) Conforming amendment to homeland security act of 2002.--
    Section 878 of the Homeland Security Act of 2002 (6 U.S.C. 458) is 
    amended--
            (A) in subsection (c), by striking ``Except as provided in 
        subsection (d), the'' and inserting ``The''; and
            (B) by striking subsection (d) and redesignating 
        subsections (e), (f), and (g) as subsections (d), (e), and (f), 
        respectively.
        (3) Technical amendments.--Section 704 (21 U.S.C. 1703) is 
    amended--
            (A) by amending subsection (g) to read as follows:
    ``(g) Inapplicability to Certain Programs.--The provisions of this 
section shall not apply to the National Intelligence Program, the Joint 
Military Intelligence Program, and Tactical and Related Activities, 
unless such program or an element of such program is designated as a 
National Drug Control Program--
        ``(1) by the President; or
        ``(2) jointly by--
            ``(A) in the case of the National Intelligence Program, the 
        Director and the Director of National Intelligence; or
            ``(B) in the case of the Joint Military Intelligence 
        Program and Tactical and Related Activities, the Director, the 
        Director of National Intelligence, and the Secretary of 
        Defense.''; and
            (B) by amending subsection (h) to read as follows:
    ``(h) Construction.--Nothing in this Act shall be construed as 
derogating the authorities and responsibilities of the Director of 
National Intelligence or the Director of the Central Intelligence 
Agency contained in the National Security Act of 1947 (50 U.S.C. 401 et 
seq.), the Central Intelligence Agency Act of 1949 (50 U.S.C. 403a et 
seq.), or any other law.''.
    SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH OTHER AGENCIES.
    Section 705 is amended--
        (1) in subsection (a)(1)(A), by striking ``abuse'';
        (2) in subsection (a)(2)(A), by striking ``Director of Central 
    Intelligence'' and inserting ``Director of National Intelligence'';
        (3) in subsection (a)(2)(B), by striking ``Director of Central 
    Intelligence'' and inserting ``Director of National Intelligence 
    and the Director of the Central Intelligence Agency'';
        (4) by amending subsection (a)(3) to read as follows:
        ``(3) Required reports.--
            ``(A) Secretaries of the interior and agriculture.--Not 
        later than July 1 of each year, the Secretaries of Agriculture 
        and the Interior shall jointly submit to the Director and the 
        appropriate congressional committees an assessment of the 
        quantity of illegal drug cultivation and manufacturing in the 
        United States on lands owned or under the jurisdiction of the 
        Federal Government for the preceding year.
            ``(B) Secretary of homeland security.--Not later than July 
        1 of each year, the Secretary of Homeland Security shall submit 
        to the Director and the appropriate congressional committees 
        information for the preceding year regarding--
                ``(i) the number and type of seizures of drugs by each 
            component of the Department of Homeland Security seizing 
            drugs, as well as statistical information on the geographic 
            areas of such seizures; and
                ``(ii) the number of air and maritime patrol hours 
            primarily dedicated to drug supply reduction missions 
            undertaken by each component of the Department of Homeland 
            Security.
            ``(C) Secretary of defense.--The Secretary of Defense 
        shall, by July 1 of each year, submit to the Director and the 
        appropriate congressional committees information for the 
        preceding year regarding the number of air and maritime patrol 
        hours primarily dedicated to drug supply reduction missions 
        undertaken by each component of the Department of Defense.
            ``(D) Attorney general.--The Attorney General shall, by 
        July 1 of each year, submit to the Director and the appropriate 
        congressional committees information for the preceding year 
        regarding the number and type of--
                ``(i) arrests for drug violations;
                ``(ii) prosecutions for drug violations by United 
            States Attorneys; and
                ``(iii) seizures of drugs by each component of the 
            Department of Justice seizing drugs, as well as statistical 
            information on the geographic areas of such seizures.'';
        (5) in subsection (b)(2)(B), by striking ``Program'' and 
    inserting ``Strategy''; and
        (6) in subsection (c), by striking ``in'' and inserting ``on''.
    SEC. 105. BUDGETARY MATTERS.
    (a) Submission of Drug Control Budget Requests.--Section 704(c)(1) 
is amended by adding at the end the following:
            ``(C) Content of drug control budget requests.--A drug 
        control budget request submitted by a department, agency, or 
        program under this paragraph shall include all requests for 
        funds for any drug control activity undertaken by that 
        department, agency, or program, including demand reduction, 
        supply reduction, and State, local, and tribal affairs, 
        including any drug law enforcement activities. If an activity 
        has both drug control and nondrug control purposes or 
        applications, the department, agency, or program shall estimate 
        by a documented calculation the total funds requested for that 
        activity that would be used for drug control, and shall set 
        forth in its request the basis and method for making the 
        estimate.''.
    (b) National Drug Control Budget Proposal.--
        (1) National organizations.--Section 704(c)(2) is amended by 
    inserting ``and the head of each major national organization that 
    represents law enforcement officers, agencies, or associations'' 
    after ``agency''.
        (2) Total budget.--Section 704(c)(2)(A) is amended by inserting 
    before the semicolon: ``and to inform Congress and the public about 
    the total amount proposed to be spent on all supply reduction, 
    demand reduction, State, local, and tribal affairs, including any 
    drug law enforcement, and other drug control activities by the 
    Federal Government, which shall conform to the content requirements 
    set forth in paragraph (1)(C)''.
    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
        (1) by redesignating subparagraphs (C) and (D) as subparagraphs 
    (D) and (E), respectively;
        (2) by inserting after subparagraph (B) the following new 
    subparagraph:
            ``(C) Specific requests.--The Director shall not confirm 
        the adequacy of any budget request that--
                ``(i) requests funding for Federal law enforcement 
            activities that do not adequately compensate for transfers 
            of drug enforcement resources and personnel to law 
            enforcement and investigation activities;
                ``(ii) requests funding for law enforcement activities 
            on the borders of the United States that do not adequately 
            direct resources to drug interdiction and enforcement;
                ``(iii) requests funding for drug treatment activities 
            that do not provide adequate results and accountability 
            measures;
                ``(iv) requests funding for any activities of the Safe 
            and Drug-Free Schools Program that do not include a clear 
            anti-drug message or purpose intended to reduce drug use;
                ``(v) requests funding for drug treatment activities 
            that do not adequately support and enhance Federal drug 
            treatment programs and capacity;
                ``(vi) requests funding for fiscal year 2007 for 
            activities of the Department of Education, unless it is 
            accompanied by a report setting forth a plan for providing 
            expedited consideration of student loan applications for 
            all individuals who submitted an application for any 
            Federal grant, loan, or work assistance that was rejected 
            or denied pursuant to 484(r)(1) of the Higher Education Act 
            of 1965 (20 U.S.C. 1091(r)(1)) by reason of a conviction 
            for a drug-related offense not occurring during a period of 
            enrollment for which the individual was receiving any 
            Federal grant, loan, or work assistance; and
                ``(vii) requests funding for the operations and 
            management of the Department of Homeland Security that does 
            not include a specific request for funds for the Office of 
            Counternarcotics Enforcement to carry out its 
            responsibilities under section 878 of the Homeland Security 
            Act of 2002 (6 U.S.C. 458).'';
        (3) in subparagraph (D)(iii), as so redesignated, by inserting 
    ``and the appropriate congressional committees'' after ``House of 
    Representatives''; and
        (4) in subparagraph (E)(ii)(II)(bb), as so redesignated, by 
    inserting ``and the appropriate congressional committees'' after 
    ``House of Representatives''.
    (d) Reprogramming and Transfer Requests.--Section 704(c)(4)(A) (21 
U.S.C. 1703(c)(4)(A)) is amended--
        (1) by striking ``$5,000,000'' and inserting ``$1,000,000''; 
    and
        (2) adding at the end the following: ``If the Director has not 
    responded to a request for reprogramming subject to this 
    subparagraph within 30 days after receiving notice of the request 
    having been made, the request shall be deemed approved by the 
    Director under this subparagraph and forwarded to Congress.''.
    (e) Powers of Director.--Section 704(d) is amended--
        (1) in paragraph (8)(D), by striking ``have been authorized by 
    Congress;'' and inserting ``authorized by law;'';
        (2) in paragraph (9), by striking ``Strategy; and'' and 
    inserting ``Strategy and notify the appropriate congressional 
    committees of any fund control notice issued; and''; and
        (3) in paragraph (10), by striking ``(22 U.S.C. 2291j).'' and 
    inserting ``(22 U.S.C. 2291j) and section 706 of the Foreign 
    Relations Authorization Act, Fiscal Year 2003 (22 U.S.C. 2291j-
    1).''.
    (f) Fund Control Notices.--Section 704(f) (21 U.S.C. 1703(f)) is 
amended by adding at the end the following:
        ``(4) Congressional notice.--A copy of each fund control notice 
    shall be transmitted to the appropriate congressional committees.
        ``(5) Restrictions.--The Director shall not issue a fund 
    control notice to direct that all or part of an amount appropriated 
    to the National Drug Control Program agency account be obligated, 
    modified, or altered in any manner contrary, in whole or in part, 
    to a specific appropriation or statute.''.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

    SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG 
      CONTROL STRATEGY.
    Section 706 is amended to read as follows:
    ``SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND ASSESSMENT 
      OF NATIONAL DRUG CONTROL STRATEGY.
    ``(a) Timing, Contents, and Process for Development and Submission 
of National Drug Control Strategy.--
        ``(1) Timing.--Not later than February 1 of each year, the 
    President shall submit to Congress a National Drug Control 
    Strategy, which shall set forth a comprehensive plan for the year 
    to reduce illicit drug use and the consequences of such illicit 
    drug use in the United States by limiting the availability of, and 
    reducing the demand for, illegal drugs.
        ``(2) Contents.--
            ``(A) In general.--The National Drug Control Strategy 
        submitted under paragraph (1) shall include the following:
                ``(i) Comprehensive, research-based, long-range, 
            quantifiable goals for reducing illicit drug use and the 
            consequences of illicit drug use in the United States.
                ``(ii) Annual quantifiable and measurable objectives 
            and specific targets to accomplish long-term quantifiable 
            goals that the Director determines may be achieved during 
            each year beginning on the date on which the National Drug 
            Control Strategy is submitted.
                ``(iii) A 5-year projection for program and budget 
            priorities.
                ``(iv) A review of international, State, local, and 
            private sector drug control activities to ensure that the 
            United States pursues coordinated and effective drug 
            control at all levels of government.
                ``(v) An assessment of current illicit drug use 
            (including inhalants and steroids) and availability, impact 
            of illicit drug use, and treatment availability, which 
            assessment shall include--

                    ``(I) estimates of drug prevalence and frequency of 
                use as measured by national, State, and local surveys 
                of illicit drug use and by other special studies of 
                nondependent and dependent illicit drug use;
                    ``(II) illicit drug use in the workplace and the 
                productivity lost by such use; and
                    ``(III) illicit drug use by arrestees, 
                probationers, and parolees.

                ``(vi) An assessment of the reduction of illicit drug 
            availability, as measured by--

                    ``(I) the quantities of cocaine, heroin, marijuana, 
                methamphetamine, ecstasy, and other drugs available for 
                consumption in the United States;
                    ``(II) the amount of marijuana, cocaine, heroin, 
                methamphetamine, ecstasy, and precursor chemicals and 
                other drugs entering the United States;
                    ``(III) the number of illicit drug manufacturing 
                laboratories seized and destroyed and the number of 
                hectares of marijuana, poppy, and coca cultivated and 
                destroyed domestically and in other countries;
                    ``(IV) the number of metric tons of marijuana, 
                heroin, cocaine, and methamphetamine seized and other 
                drugs; and
                    ``(V) changes in the price and purity of heroin, 
                methamphetamine, and cocaine, changes in the price of 
                ecstasy, and changes in tetrahydrocannabinol level of 
                marijuana and other drugs.

                ``(vii) An assessment of the reduction of the 
            consequences of illicit drug use and availability, which 
            shall include--

                    ``(I) the burden illicit drug users placed on 
                hospital emergency departments in the United States, 
                such as the quantity of illicit drug-related services 
                provided;
                    ``(II) the annual national health care cost of 
                illicit drug use; and
                    ``(III) the extent of illicit drug-related crime 
                and criminal activity.

                ``(viii) A determination of the status of drug 
            treatment in the United States, by assessing--

                    ``(I) public and private treatment utilization; and
                    ``(II) the number of illicit drug users the 
                Director estimates meet diagnostic criteria for 
                treatment.

                ``(ix) A review of the research agenda of the 
            Counterdrug Technology Assessment Center to reduce the 
            availability and abuse of drugs.
                ``(x) A summary of the efforts made to coordinate with 
            private sector entities to conduct private research and 
            development of medications to treat addiction by--

                    ``(I) screening chemicals for potential therapeutic 
                value;
                    ``(II) developing promising compounds;
                    ``(III) conducting clinical trials;
                    ``(IV) seeking Food and Drug Administration 
                approval for drugs to treat addiction;
                    ``(V) marketing the drug for the treatment of 
                addiction;
                    ``(VI) urging physicians to use the drug in the 
                treatment of addiction; and
                    ``(VII) encouraging insurance companies to 
                reimburse the cost of the drug for the treatment of 
                addiction.

                ``(xi) An assessment of Federal effectiveness in 
            achieving the National Drug Control Strategy for the 
            previous year, including a specific evaluation of whether 
            the objectives and targets for reducing illicit drug use 
            for the previous year were met and reasons for the success 
            or failure of the previous year's Strategy.
                ``(xii) A general review of the status of, and trends 
            in, demand reduction activities by private sector entities 
            and community-based organizations, including faith-based 
            organizations, to determine their effectiveness and the 
            extent of cooperation, coordination, and mutual support 
            between such entities and organizations and Federal, State, 
            local, and tribal government agencies.
                ``(xiii) Such additional statistical data and 
            information as the Director considers appropriate to 
            demonstrate and assess trends relating to illicit drug use, 
            the effects and consequences of illicit drug use (including 
            the effects on children of substance abusers), supply 
            reduction, demand reduction, drug-related law enforcement, 
            and the implementation of the National Drug Control 
            Strategy.
                ``(xiv) A supplement reviewing the activities of each 
            individual National Drug Control Program agency during the 
            previous year with respect to the National Drug Control 
            Strategy and the Director's assessment of the progress of 
            each National Drug Control Program agency in meeting its 
            responsibilities under the National Drug Control Strategy.
            ``(B) Classified information.--Any contents of the National 
        Drug Control Strategy that involve information properly 
        classified under criteria established by an Executive order 
        shall be presented to Congress separately from the rest of the 
        National Drug Control Strategy.
            ``(C) Selection of data and information.--In selecting data 
        and information for inclusion under subparagraph (A), the 
        Director shall ensure--
                ``(i) the inclusion of data and information that will 
            permit analysis of current trends against previously 
            compiled data and information where the Director believes 
            such analysis enhances long-term assessment of the National 
            Drug Control Strategy; and
                ``(ii) the inclusion of data and information to permit 
            a standardized and uniform assessment of the effectiveness 
            of drug treatment programs in the United States.
        ``(3) Process for development and submission.--In developing 
    and effectively implementing the National Drug Control Strategy, 
    the Director--
            ``(A) shall consult with--
                ``(i) the heads of the National Drug Control Program 
            agencies;
                ``(ii) Congress;
                ``(iii) State, local, and tribal officials;
                ``(iv) private citizens and organizations, including 
            community and faith-based organizations with experience and 
            expertise in demand reduction;
                ``(v) private citizens and organizations with 
            experience and expertise in supply reduction; and
                ``(vi) appropriate representatives of foreign 
            governments;
            ``(B) in satisfying the requirements of subparagraph (A), 
        shall ensure, to the maximum extent possible, that State, 
        local, and tribal officials and relevant private organizations 
        commit to support and take steps to achieve the goals and 
        objectives of the National Drug Control Strategy;
            ``(C) with the concurrence of the Attorney General, may 
        require the El Paso Intelligence Center to undertake specific 
        tasks or projects to support or implement the National Drug 
        Control Strategy; and
            ``(D) with the concurrence of the Director of National 
        Intelligence and the Attorney General, may request that the 
        National Drug Intelligence Center undertake specific tasks or 
        projects to support or implement the National Drug Control 
        Strategy.
    ``(b) Submission of Revised Strategy.--The President may submit to 
Congress a revised National Drug Control Strategy that meets the 
requirements of this section--
        ``(1) at any time, upon a determination of the President, in 
    consultation with the Director, that the National Drug Control 
    Strategy in effect is not sufficiently effective; or
        ``(2) if a new President or Director takes office.''.
    SEC. 202. PERFORMANCE MEASUREMENTS.
    Section 706 is amended by adding at the end the following:
    ``(c) Performance Measurement System.--Not later than February 1 of 
each year, the Director shall submit to Congress as part of the 
National Drug Control Strategy, a description of a national drug 
control performance measurement system, that--
        ``(1) develops 2-year and 5-year performance measures and 
    targets for each National Drug Control Strategy goal and objective 
    established for reducing drug use, availability, and the 
    consequences of drug use;
        ``(2) describes the sources of information and data that will 
    be used for each performance measure incorporated into the 
    performance measurement system;
        ``(3) identifies major programs and activities of the National 
    Drug Control Program agencies that support the goals and annual 
    objectives of the National Drug Control Strategy;
        ``(4) evaluates the contribution of demand reduction and supply 
    reduction activities as defined in section 702 implemented by each 
    National Drug Control Program agency in support of the National 
    Drug Control Strategy;
        ``(5) monitors consistency between the drug-related goals and 
    objectives of the National Drug Control Program agencies and 
    ensures that each agency's goals and budgets support and are fully 
    consistent with the National Drug Control Strategy; and
        ``(6) coordinates the development and implementation of 
    national drug control data collection and reporting systems to 
    support policy formulation and performance measurement, including 
    an assessment of--
            ``(A) the quality of current drug use measurement 
        instruments and techniques to measure supply reduction and 
        demand reduction activities;
            ``(B) the adequacy of the coverage of existing national 
        drug use measurement instruments and techniques to measure the 
        illicit drug user population, and groups that are at risk for 
        illicit drug use;
            ``(C) the adequacy of the coverage of existing national 
        treatment outcome monitoring systems to measure the 
        effectiveness of drug abuse treatment in reducing illicit drug 
        use and criminal behavior during and after the completion of 
        substance abuse treatment; and
            ``(D) the actions the Director shall take to correct any 
        deficiencies and limitations identified pursuant to 
        subparagraphs (A) and (B) of this subsection.
    ``(d) Modifications.--A description of any modifications made 
during the preceding year to the national drug performance measurement 
system described in subsection (c) shall be included in each report 
submitted under subsection (b).''.
    SEC. 203. ANNUAL REPORT REQUIREMENT.
    (a) In General.--On or before February 1 of each year, the Director 
shall submit a report to Congress that describes--
        (1) the strategy of the national media campaign and whether 
    specific objectives of the campaign were accomplished;
        (2) steps taken to ensure that the national media campaign 
    operates in an effective and efficient manner consistent with the 
    overall strategy and focus of the campaign;
        (3) plans to purchase advertising time and space;
        (4) policies and practices implemented to ensure that Federal 
    funds are used responsibly to purchase advertising time and space 
    and eliminate the potential for waste, fraud, and abuse;
        (5) all contracts entered into with a corporation, partnership, 
    or individual working on behalf of the national media campaign;
        (6) specific policies and steps implemented to ensure 
    compliance with title IV of this Act;
        (7) steps taken to ensure that the national media campaign will 
    secure, to the maximum extent possible, no cost matches of 
    advertising time and space or in-kind contributions that are 
    directly related to the campaign in accordance with title IV of 
    this Act; and
        (8) a review and evaluation of the effectiveness of the 
    national media campaign strategy for the past year.
    (b) Audit.--The Government Accountability Office shall, at a 
frequency of not less than once per year--
        (1) conduct and supervise an audit and investigation relating 
    to the programs and operations of the--
            (A) Office; or
            (B) certain programs within the Office, including--
                (i) the High Intensity Drug Trafficking Areas Program;
                (ii) the Counterdrug Technology Assessment Center; or
                (iii) the National Youth Anti-drug Media Campaign; and
        (2) provide the Director and the appropriate congressional 
    committees with a report containing an evaluation of and 
    recommendations on the--
            (A) policies and activities of the programs and operations 
        subject to the audit and investigation;
            (B) economy, efficiency, and effectiveness in the 
        administration of the reviewed programs and operations; and
            (C) policy or management changes needed to prevent and 
        detect fraud and abuse in such programs and operations.

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

    SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.
    Section 707 is amended to read as follows:
    ``SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.
    ``(a) Establishment.--
        ``(1) In general.--There is established in the Office a program 
    to be known as the High Intensity Drug Trafficking Areas Program 
    (in this section referred to as the `Program').
        ``(2) Purpose.--The purpose of the Program is to reduce drug 
    trafficking and drug production in the United States by--
            ``(A) facilitating cooperation among Federal, State, local, 
        and tribal law enforcement agencies to share information and 
        implement coordinated enforcement activities;
            ``(B) enhancing law enforcement intelligence sharing among 
        Federal, State, local, and tribal law enforcement agencies;
            ``(C) providing reliable law enforcement intelligence to 
        law enforcement agencies needed to design effective enforcement 
        strategies and operations; and
            ``(D) supporting coordinated law enforcement strategies 
        which maximize use of available resources to reduce the supply 
        of illegal drugs in designated areas and in the United States 
        as a whole.
    ``(b) Designation.--
        ``(1) In general.--The Director, in consultation with the 
    Attorney General, the Secretary of the Treasury, the Secretary of 
    Homeland Security, heads of the National Drug Control Program 
    agencies, and the Governor of each applicable State, may designate 
    any specified area of the United States as a high intensity drug 
    trafficking area.
        ``(2) Activities.--After making a designation under paragraph 
    (1) and in order to provide Federal assistance to the area so 
    designated, the Director may--
            ``(A) obligate such sums as are appropriated for the 
        Program;
            ``(B) direct the temporary reassignment of Federal 
        personnel to such area, subject to the approval of the head of 
        the department or agency that employs such personnel;
            ``(C) take any other action authorized under section 704 to 
        provide increased Federal assistance to those areas; and
            ``(D) coordinate activities under this section 
        (specifically administrative, recordkeeping, and funds 
        management activities) with State, local, and tribal officials.
    ``(c) Petitions for Designation.--The Director shall establish 
regulations under which a coalition of interested law enforcement 
agencies from an area may petition for designation as a high intensity 
drug trafficking area. Such regulations shall provide for a regular 
review by the Director of the petition, including a recommendation 
regarding the merit of the petition to the Director by a panel of 
qualified, independent experts.
    ``(d) Factors for Consideration.--In considering whether to 
designate an area under this section as a high intensity drug 
trafficking area, the Director shall consider, in addition to such 
other criteria as the Director considers to be appropriate, the extent 
to which--
        ``(1) the area is a significant center of illegal drug 
    production, manufacturing, importation, or distribution;
        ``(2) State, local, and tribal law enforcement agencies have 
    committed resources to respond to the drug trafficking problem in 
    the area, thereby indicating a determination to respond 
    aggressively to the problem;
        ``(3) drug-related activities in the area are having a 
    significant harmful impact in the area, and in other areas of the 
    country; and
        ``(4) a significant increase in allocation of Federal resources 
    is necessary to respond adequately to drug-related activities in 
    the area.
    ``(e) Organization of High Intensity Drug Trafficking Areas.--
        ``(1) Executive board and officers.--To be eligible for funds 
    appropriated under this section, each high intensity drug 
    trafficking area shall be governed by an Executive Board. The 
    Executive Board shall designate a chairman, vice chairman, and any 
    other officers to the Executive Board that it determines are 
    necessary.
        ``(2) Responsibilities.--The Executive Board of a high 
    intensity drug trafficking area shall be responsible for--
            ``(A) providing direction and oversight in establishing and 
        achieving the goals of the high intensity drug trafficking 
        area;
            ``(B) managing the funds of the high intensity drug 
        trafficking area;
            ``(C) reviewing and approving all funding proposals 
        consistent with the overall objective of the high intensity 
        drug trafficking area; and
            ``(D) reviewing and approving all reports to the Director 
        on the activities of the high intensity drug trafficking area.
        ``(3) Board representation.--None of the funds appropriated 
    under this section may be expended for any high intensity drug 
    trafficking area, or for a partnership or region of a high 
    intensity drug trafficking area, if the Executive Board for such 
    area, region, or partnership, does not apportion an equal number of 
    votes between representatives of participating Federal agencies and 
    representatives of participating State, local, and tribal agencies. 
    Where it is impractical for an equal number of representatives of 
    Federal agencies and State, local, and tribal agencies to attend a 
    meeting of an Executive Board in person, the Executive Board may 
    use a system of proxy votes or weighted votes to achieve the voting 
    balance required by this paragraph.
        ``(4) No agency relationship.--The eligibility requirements of 
    this section are intended to ensure the responsible use of Federal 
    funds. Nothing in this section is intended to create an agency 
    relationship between individual high intensity drug trafficking 
    areas and the Federal Government.
    ``(f) Use of Funds.--The Director shall ensure that no Federal 
funds appropriated for the Program are expended for the establishment 
or expansion of drug treatment programs, and shall ensure that not more 
than 5 percent of the Federal funds appropriated for the Program are 
expended for the establishment of drug prevention programs.
    ``(g) Counterterrorism Activities.--
        ``(1) Assistance authorized.--The Director may authorize use of 
    resources available for the Program to assist Federal, State, 
    local, and tribal law enforcement agencies in investigations and 
    activities related to terrorism and prevention of terrorism, 
    especially but not exclusively with respect to such investigations 
    and activities that are also related to drug trafficking.
        ``(2) Limitation.--The Director shall ensure--
            ``(A) that assistance provided under paragraph (1) remains 
        incidental to the purpose of the Program to reduce drug 
        availability and carry out drug-related law enforcement 
        activities; and
            ``(B) that significant resources of the Program are not 
        redirected to activities exclusively related to terrorism, 
        except on a temporary basis under extraordinary circumstances, 
        as determined by the Director.
    ``(h) Role of Drug Enforcement Administration.--The Director, in 
consultation with the Attorney General, shall ensure that a 
representative of the Drug Enforcement Administration is included in 
the Intelligence Support Center for each high intensity drug 
trafficking area.
    ``(i) Annual HIDTA Program Budget Submissions.--As part of the 
documentation that supports the President's annual budget request for 
the Office, the Director shall submit to Congress a budget 
justification that includes--
        ``(1) the amount proposed for each high intensity drug 
    trafficking area, conditional upon a review by the Office of the 
    request submitted by the HIDTA and the performance of the HIDTA, 
    with supporting narrative descriptions and rationale for each 
    request;
        ``(2) a detailed justification that explains--
            ``(A) the reasons for the proposed funding level; how such 
        funding level was determined based on a current assessment of 
        the drug trafficking threat in each high intensity drug 
        trafficking area;
            ``(B) how such funding will ensure that the goals and 
        objectives of each such area will be achieved; and
            ``(C) how such funding supports the National Drug Control 
        Strategy; and
        ``(3) the amount of HIDTA funds used to investigate and 
    prosecute organizations and individuals trafficking in 
    methamphetamine in the prior calendar year, and a description of 
    how those funds were used.
    ``(j) Emerging Threat Response Fund.--
        ``(1) In general.--Subject to the availability of 
    appropriations, the Director may expend up to 10 percent of the 
    amounts appropriated under this section on a discretionary basis, 
    to respond to any emerging drug trafficking threat in an existing 
    high intensity drug trafficking area, or to establish a new high 
    intensity drug trafficking area or expand an existing high 
    intensity drug trafficking area, in accordance with the criteria 
    established under paragraph (2).
        ``(2) Consideration of impact.--In allocating funds under this 
    subsection, the Director shall consider--
            ``(A) the impact of activities funded on reducing overall 
        drug traffic in the United States, or minimizing the 
        probability that an emerging drug trafficking threat will 
        spread to other areas of the United States; and
            ``(B) such other criteria as the Director considers 
        appropriate.
    ``(k) Evaluation.--
        ``(1) Initial report.--Not later than 90 days after the date of 
    the enactment of this section, the Director shall, after consulting 
    with the Executive Boards of each designated high intensity drug 
    trafficking area, submit a report to Congress that describes, for 
    each designated high intensity drug trafficking area--
            ``(A) the specific purposes for the high intensity drug 
        trafficking area;
            ``(B) the specific long-term and short-term goals and 
        objectives for the high intensity drug trafficking area;
            ``(C) the measurements that will be used to evaluate the 
        performance of the high intensity drug trafficking area in 
        achieving the long-term and short-term goals; and
            ``(D) the reporting requirements needed to evaluate the 
        performance of the high intensity drug trafficking area in 
        achieving the long-term and short-term goals.
        ``(2) Evaluation of hidta program as part of national drug 
    control strategy.--For each designated high intensity drug 
    trafficking area, the Director shall submit, as part of the annual 
    National Drug Control Strategy report, a report that--
            ``(A) describes--
                ``(i) the specific purposes for the high intensity drug 
            trafficking area; and
                ``(ii) the specific long-term and short-term goals and 
            objectives for the high intensity drug trafficking area; 
            and
            ``(B) includes an evaluation of the performance of the high 
        intensity drug trafficking area in accomplishing the specific 
        long-term and short-term goals and objectives identified under 
        paragraph (1)(B).
    ``(l) Assessment of Drug Enforcement Task Forces in High Intensity 
Drug Trafficking Areas.--Not later than 1 year after the date of 
enactment of this subsection, and as part of each subsequent annual 
National Drug Control Strategy report, the Director shall submit to 
Congress a report--
        ``(1) assessing the number and operation of all federally 
    funded drug enforcement task forces within each high intensity drug 
    trafficking area; and
        ``(2) describing--
            ``(A) each Federal, State, local, and tribal drug 
        enforcement task force operating in the high intensity drug 
        trafficking area;
            ``(B) how such task forces coordinate with each other, with 
        any high intensity drug trafficking area task force, and with 
        investigations receiving funds from the Organized Crime and 
        Drug Enforcement Task Force;
            ``(C) what steps, if any, each such task force takes to 
        share information regarding drug trafficking and drug 
        production with other federally funded drug enforcement task 
        forces in the high intensity drug trafficking area;
            ``(D) the role of the high intensity drug trafficking area 
        in coordinating the sharing of such information among task 
        forces;
            ``(E) the nature and extent of cooperation by each Federal, 
        State, local, and tribal participant in ensuring that such 
        information is shared among law enforcement agencies and with 
        the high intensity drug trafficking area;
            ``(F) the nature and extent to which information sharing 
        and enforcement activities are coordinated with joint terrorism 
        task forces in the high intensity drug trafficking area; and
            ``(G) any recommendations for measures needed to ensure 
        that task force resources are utilized efficiently and 
        effectively to reduce the availability of illegal drugs in the 
        high intensity drug trafficking areas.
    ``(m) Assessment of Law Enforcement Intelligence Sharing in High 
Intensity Drug Trafficking Areas Program.--Not later than 180 days 
after the date of the enactment of this section, and as part of each 
subsequent annual National Drug Control Strategy report, the Director, 
in consultation with the Director of National Intelligence, shall 
submit to Congress a report--
        ``(1) evaluating existing and planned law enforcement 
    intelligence systems supported by each high intensity drug 
    trafficking area, or utilized by task forces receiving any funding 
    under the Program, including the extent to which such systems 
    ensure access and availability of law enforcement intelligence to 
    Federal, State, local, and tribal law enforcement agencies within 
    the high intensity drug trafficking area and outside of it;
        ``(2) the extent to which Federal, State, local, and tribal law 
    enforcement agencies participating in each high intensity drug 
    trafficking area are sharing law enforcement intelligence 
    information to assess current drug trafficking threats and design 
    appropriate enforcement strategies; and
        ``(3) the measures needed to improve effective sharing of 
    information and law enforcement intelligence regarding drug 
    trafficking and drug production among Federal, State, local, and 
    tribal law enforcement participating in a high intensity drug 
    trafficking area, and between such agencies and similar agencies 
    outside the high intensity drug trafficking area.
    ``(n) Coordination of Law Enforcement Intelligence Sharing With 
Organized Crime Drug Enforcement Task Force Program.--The Director, in 
consultation with the Attorney General, shall ensure that any drug 
enforcement intelligence obtained by the Intelligence Support Center 
for each high intensity drug trafficking area is shared, on a timely 
basis, with the drug intelligence fusion center operated by the 
Organized Crime Drug Enforcement Task Force of the Department of 
Justice.
    ``(o) Use of Funds To Combat Methamphetamine Trafficking.--
        ``(1) Requirement.--As part of the documentation that supports 
    the President's annual budget request for the Office, the Director 
    shall submit to Congress a report describing the use of HIDTA funds 
    to investigate and prosecute organizations and individuals 
    trafficking in methamphetamine in the prior calendar year.
        ``(2) Contents.--The report shall include--
            ``(A) the number of methamphetamine manufacturing 
        facilities discovered through HIDTA-funded initiatives in the 
        previous fiscal year;
            ``(B) the amounts of methamphetamine or listed chemicals 
        (as that term is defined in section 102(33) of the Controlled 
        Substances Act (21 U.S.C. 802(33)) seized by HIDTA-funded 
        initiatives in the area during the previous year; and
            ``(C) law enforcement intelligence and predictive data from 
        the Drug Enforcement Administration showing patterns and trends 
        in abuse, trafficking, and transportation in methamphetamine 
        and listed chemicals.
        ``(3) Certification.--Before the Director awards any funds to a 
    high intensity drug trafficking area, the Director shall certify 
    that the law enforcement entities participating in that HIDTA are 
    providing laboratory seizure data to the national clandestine 
    laboratory database at the El Paso Intelligence Center.
    ``(p) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office of National Drug Control Policy to carry out 
this section--
        ``(1) $240,000,000 for fiscal year 2007;
        ``(2) $250,000,000 for fiscal year 2008;
        ``(3) $260,000,000 for fiscal year 2009;
        ``(4) $270,000,000 for fiscal year 2010; and
        ``(5) $280,000,000 for each of fiscal year 2011.''.
    SEC. 302. FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAFFICKING 
      AREAS.
    (a) Short Title.--This section may be cited as the ``Dawson Family 
Community Protection Act''.
    (b) Findings.--Congress finds the following:
        (1) In the early morning hours of October 16, 2002, the home of 
    Carnell and Angela Dawson was firebombed in apparent retaliation 
    for Mrs. Dawson's notification to police about persistent drug 
    distribution activity in their East Baltimore City neighborhood.
        (2) The arson claimed the lives of Mr. and Mrs. Dawson and 
    their 5 young children, aged 9 to 14.
        (3) The horrific murder of the Dawson family is a stark example 
    of domestic narco-terrorism.
        (4) In all phases of counternarcotics law enforcement--from 
    prevention to investigation to prosecution to reentry--the 
    voluntary cooperation of ordinary citizens is a critical component.
        (5) Voluntary cooperation is difficult for law enforcement 
    officials to obtain when citizens feel that cooperation carries the 
    risk of violent retaliation by illegal drug trafficking 
    organizations and their affiliates.
        (6) Public confidence that law enforcement is doing all it can 
    to make communities safe is a prerequisite for voluntary 
    cooperation among people who may be subject to intimidation or 
    reprisal (or both).
        (7) Witness protection programs are insufficient on their own 
    to provide security because many individuals and families who 
    strive every day to make distressed neighborhoods livable for their 
    children, other relatives, and neighbors will resist or refuse 
    offers of relocation by local, State, and Federal prosecutorial 
    agencies and because, moreover, the continued presence of strong 
    individuals and families is critical to preserving and 
    strengthening the social fabric in such communities.
        (8) Where (as in certain sections of Baltimore City) interstate 
    trafficking of illegal drugs has severe ancillary local 
    consequences within areas designated as high intensity drug 
    trafficking areas, it is important that supplementary High 
    Intensity Drug Trafficking Areas Program funds be committed to 
    support initiatives aimed at making the affected communities safe 
    for the residents of those communities and encouraging their 
    cooperation with tribal, local, State, and Federal law enforcement 
    efforts to combat illegal drug trafficking.
    (c) Funding for Certain High Intensity Drug Trafficking Areas.--
Section 707, as amended by section 301, is amended by adding at the end 
the following:
    ``(q) Specific Purposes.--
        ``(1) In general.--The Director shall ensure that, of the 
    amounts appropriated for a fiscal year for the Program, at least 
    $7,000,000 is used in high intensity drug trafficking areas with 
    severe neighborhood safety and illegal drug distribution problems.
        ``(2) Required uses.--The funds used under paragraph (1) shall 
    be used--
            ``(A) to ensure the safety of neighborhoods and the 
        protection of communities, including the prevention of the 
        intimidation of potential witnesses of illegal drug 
        distribution and related activities; and
            ``(B) to combat illegal drug trafficking through such 
        methods as the Director considers appropriate, such as 
        establishing or operating (or both) a toll-free telephone 
        hotline for use by the public to provide information about 
        illegal drug-related activities.''.
    SEC. 303. ASSESSMENT.
    The Director shall assess the ability of the HIDTA Program to 
respond to the so-called ``balloon effect'', whereby urban drug 
traffickers facing intensive law enforcement efforts expand and spread 
their trafficking and distribution into rural, suburban, and smaller 
urban areas by conducting a demonstration project examining the ability 
of the New York/New Jersey HIDTA, with its new single colocated 
Organized Crime and Drug Enforcement Task Force/High Intensity Drug 
Trafficking Area Strike Force and HIDTA Regional Intelligence Center, 
to address the movement of drug traffickers into the more rural, 
suburban, and smaller areas encompassed by the counties of Albany, 
Onondaga, Monroe, and Erie in New York State and by annexing these 
counties into the existing New York/New Jersey HIDTA.

                          TITLE IV--TECHNOLOGY

    SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CENTER.
    (a) Chief Scientist.--Section 708(b) is amended to read as follows:
    ``(b) Chief Scientist.--There shall be at the head of the Center 
the Chief Scientist, who shall be appointed by the Director from among 
individuals qualified and distinguished in the area of science, 
medicine, engineering, or technology.''.
    (b) Responsibilities.--
        (1) Research and development.--Section 708 is amended by--
            (A) redesignating subsection (d) as subsection (e); and
            (B) striking subsection (c) and inserting the following:
    ``(c) Research and Development Responsibilities.--The Director, 
acting through the Chief Scientist, shall--
        ``(1) identify and define the short-, medium-, and long-term 
    scientific and technological needs of Federal, State, local, and 
    tribal drug supply reduction agencies, including--
            ``(A) advanced surveillance, tracking, and radar imaging;
            ``(B) electronic support measures;
            ``(C) communications;
            ``(D) data fusion, advanced computer systems, and 
        artificial intelligence; and
            ``(E) chemical, biological, radiological (including neutron 
        and electron), and other means of detection;
        ``(2) identify demand reduction basic and applied research 
    needs and initiatives, in consultation with affected National Drug 
    Control Program agencies, including--
            ``(A) improving treatment through neuroscientific advances;
            ``(B) improving the transfer of biomedical research to the 
        clinical setting; and
            ``(C) in consultation with the National Institute of Drug 
        Abuse and the Substance Abuse and Mental Health Services 
        Administration, and through interagency agreements or grants, 
        examining addiction and rehabilitation research and the 
        application of technology to expanding the effectiveness and 
        availability of drug treatment;
        ``(3) make a priority ranking of such needs identified in 
    paragraphs (1) and (2) according to fiscal and technological 
    feasibility, as part of a National Counterdrug Research and 
    Development Program;
        ``(4) oversee and coordinate counterdrug technology initiatives 
    with related activities of other Federal civilian and military 
    departments;
        ``(5) provide support to the development and implementation of 
    the national drug control performance measurement system 
    established under subsection (c) of section 706; and
        ``(6) pursuant to the authority of the Director of National 
    Drug Control Policy under section 704, submit requests to Congress 
    for the reprogramming or transfer of funds appropriated for 
    counterdrug technology research and development.
    ``(d) Limitation on Authority.--The authority granted to the 
Director under this section shall not extend to the awarding of 
contracts, management of individual projects, or other operational 
activities.''.
        (2) Assistance and support.--Subsection (e) of section 708, as 
    redesignated by this section, is amended to read as follows:
    ``(e) Assistance and Support to the Office of National Drug Control 
Policy.--The Secretary of Defense, the Secretary of Homeland Security, 
and the Secretary of Health and Human Services shall, to the maximum 
extent practicable, render assistance and support to the Office and to 
the Director in the conduct of counterdrug technology assessment.''.
        (3) Technology transfer program.--Section 708 is amended by 
    adding at the end the following:
    ``(f) Technology Transfer Program.--
        ``(1) Program.--The Chief Scientist, with the advice and 
    counsel of experts from State, local, and tribal law enforcement 
    agencies, shall be responsible to the Director for coordination and 
    implementation of a counterdrug technology transfer program.
        ``(2) Purpose.--The purpose of the Technology Transfer Program 
    shall be for the Counterdrug Technology Assessment Center to 
    transfer technology and associated training directly to State, 
    local, and tribal law enforcement agencies.
        ``(3) Priority of receipts.--Transfers shall be made in 
    priority order based on--
            ``(A) the need of potential recipients for such technology;
            ``(B) the effectiveness of the technology to enhance 
        current counterdrug activities of potential recipients; and
            ``(C) the ability and willingness of potential recipients 
        to evaluate transferred technology.
        ``(4) Agreement authority.--The Director may enter into an 
    agreement with the Secretary of Homeland Security to transfer 
    technology with both counterdrug and homeland security applications 
    to State, local, and tribal law enforcement agencies on a 
    reimbursable basis.
        ``(5) Report.--On or before July 1 of each year, the Director 
    shall submit a report to the appropriate congressional committees 
    that addresses the following:
            ``(A) The number of requests received during the previous 
        12 months, including the identity of each requesting agency and 
        the type of technology requested.
            ``(B) The number of requests fulfilled during the previous 
        12 months, including the identity of each recipient agency and 
        the type of technology transferred.
            ``(C) A summary of the criteria used in making the 
        determination on what requests were funded and what requests 
        were not funded, except that such summary shall not include 
        specific information on any individual requests.
            ``(D) A general assessment of the future needs of the 
        program, based on expected changes in threats, expected 
        technologies, and likely need from potential recipients.
            ``(E) An assessment of the effectiveness of the 
        technologies transferred, based in part on the evaluations 
        provided by the recipients, with a recommendation whether the 
        technology should continue to be offered through the 
        program.''.
    (c) Assistance From Secretary of Homeland Security.--Section 708(d) 
(21 U.S.C. 1707(d)) is amended by inserting ``, the Secretary of 
Homeland Security,'' after ``The Secretary of Defense''.

                 TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN

    SEC. 501. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.
    (a) In General.--Section 709 (21 U.S.C. 1708) is amended to read as 
follows:
    ``SEC. 709. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.
    ``(a) In General.--The Director shall conduct a national youth 
anti-drug media campaign (referred to in this subtitle as the `national 
media campaign') in accordance with this section for the purposes of--
        ``(1) preventing drug abuse among young people in the United 
    States;
        ``(2) increasing awareness of adults of the impact of drug 
    abuse on young people; and
        ``(3) encouraging parents and other interested adults to 
    discuss with young people the dangers of illegal drug use.
    ``(b) Use of Funds.--
        ``(1) In general.--Amounts made available to carry out this 
    section for the national media campaign may only be used for the 
    following:
            ``(A) The purchase of media time and space, including the 
        strategic planning for, and accounting of, such purchases.
            ``(B) Creative and talent costs, consistent with paragraph 
        (2)(A).
            ``(C) Advertising production costs.
            ``(D) Testing and evaluation of advertising.
            ``(E) Evaluation of the effectiveness of the national media 
        campaign.
            ``(F) The negotiated fees for the winning bidder on 
        requests for proposals issued either by the Office or its 
        designee to enter into contracts to carry out activities 
        authorized by this section.
            ``(G) Partnerships with professional and civic groups, 
        community-based organizations, including faith-based 
        organizations, and government organizations related to the 
        national media campaign.
            ``(H) Entertainment industry outreach, interactive 
        outreach, media projects and activities, public information, 
        news media outreach, and corporate sponsorship and 
        participation.
            ``(I) Operational and management expenses.
        ``(2) Specific requirements.--
            ``(A) Creative services.--
                ``(i) In using amounts for creative and talent costs 
            under paragraph (1)(B), the Director shall use creative 
            services donated at no cost to the Government (including 
            creative services provided by the Partnership for a Drug-
            Free America) wherever feasible and may only procure 
            creative services for advertising--

                    ``(I) responding to high-priority or emergent 
                campaign needs that cannot timely be obtained at no 
                cost; or
                    ``(II) intended to reach a minority, ethnic, or 
                other special audience that cannot reasonably be 
                obtained at no cost; or
                    ``(III) the Director determines that the 
                Partnership for a Drug-Free America is unable to 
                provide, pursuant to subsection (d)(2)(B).

                ``(ii) Subject to the availability of appropriations, 
            no more than $1,500,000 may be expended under this section 
            each fiscal year on creative services, except that the 
            Director may expend up to $2,000,000 in a fiscal year on 
            creative services to meet urgent needs of the national 
            media campaign with advance approval from the Committee on 
            Appropriations of the Senate and of the House of 
            Representatives upon a showing of the circumstances causing 
            such urgent needs of the national media campaign.
            ``(B) Testing and evaluation of advertising.--In using 
        amounts for testing and evaluation of advertising under 
        paragraph (1)(D), the Director shall test all advertisements 
        prior to use in the national media campaign to ensure that the 
        advertisements are effective and meet industry-accepted 
        standards. The Director may waive this requirement for 
        advertisements using no more than 10 percent of the purchase of 
        advertising time purchased under this section in a fiscal year 
        and no more than 10 percent of the advertising space purchased 
        under this section in a fiscal year, if the advertisements 
        respond to emergent and time-sensitive campaign needs or the 
        advertisements will not be widely utilized in the national 
        media campaign.
            ``(C) Evaluation of effectiveness of media campaign.--In 
        using amounts for the evaluation of the effectiveness of the 
        national media campaign under paragraph (1)(E), the Director 
        shall--
                ``(i) designate an independent entity to evaluate by 
            April 20 of each year the effectiveness of the national 
            media campaign based on data from--

                    ``(I) the Monitoring the Future Study published by 
                the Department of Health and Human Services;
                    ``(II) the Attitude Tracking Study published by the 
                Partnership for a Drug-Free America;
                    ``(III) the National Household Survey on Drug 
                Abuse; and
                    ``(IV) other relevant studies or publications, as 
                determined by the Director, including tracking and 
                evaluation data collected according to marketing and 
                advertising industry standards; and

                ``(ii) ensure that the effectiveness of the national 
            media campaign is evaluated in a manner that enables 
            consideration of whether the national media campaign has 
            contributed to reduction of illicit drug use among youth 
            and such other measures of evaluation as the Director 
            determines are appropriate.
        ``(3) Purchase of advertising time and space.--Subject to the 
    availability of appropriations, for each fiscal year, not less than 
    77 percent of the amounts appropriated under this section shall be 
    used for the purchase of advertising time and space for the 
    national media campaign, subject to the following exceptions:
            ``(A) In any fiscal year for which less than $125,000,000 
        is appropriated for the national media campaign, not less than 
        72 percent of the amounts appropriated under this section shall 
        be used for the purchase of advertising time and space for the 
        national media campaign.
            ``(B) In any fiscal year for which more than $195,000,000 
        is appropriated under this section, not less than 82 percent 
        shall be used for advertising production costs and the purchase 
        of advertising time and space for the national media campaign.
    ``(c) Advertising.--In carrying out this section, the Director 
shall ensure that sufficient funds are allocated to meet the stated 
goals of the national media campaign.
    ``(d) Division of Responsibilities and Functions Under the 
Program.--
        ``(1) In general.--The Director, in consultation with the 
    Partnership for a Drug-Free America, shall determine the overall 
    purposes and strategy of the national media campaign.
        ``(2) Responsibilities.--
            ``(A) Director.--The Director shall be responsible for 
        implementing a focused national media campaign to meet the 
        purposes set forth in subsection (a), and shall approve--
                ``(i) the strategy of the national media campaign;
                ``(ii) all advertising and promotional material used in 
            the national media campaign; and
                ``(iii) the plan for the purchase of advertising time 
            and space for the national media campaign.
            ``(B) The partnership for a drug-free america.--The 
        Director shall request that the Partnership for a Drug-Free 
        America--
                ``(i) develop and recommend strategies to achieve the 
            goals of the national media campaign, including addressing 
            national and local drug threats in specific regions or 
            States, such as methamphetamine and ecstasy;
                ``(ii) create all advertising to be used in the 
            national media campaign, except advertisements that are--

                    ``(I) provided by other nonprofit entities pursuant 
                to subsection (f);
                    ``(II) intended to respond to high-priority or 
                emergent campaign needs that cannot timely be obtained 
                at no cost (not including production costs and talent 
                reuse payments), provided that any such advertising 
                material is reviewed by the Partnership for a Drug-Free 
                America;
                    ``(III) intended to reach a minority, ethnic, or 
                other special audience that cannot be obtained at no 
                cost (not including production costs and talent reuse 
                payments), provided that any such advertising material 
                is reviewed by the Partnership for a Drug-Free America; 
                or
                    ``(IV) any other advertisements that the Director 
                determines that the Partnership for a Drug-Free America 
                is unable to provide or if the Director determines that 
                another entity is more appropriate, subject to the 
                requirements of subsection (b)(2)(A).

        If the Director determines that another entity is more 
        appropriate under clause (ii)(IV), the Director shall notify 
        Congress, through the committees of jurisdiction in the House 
        and Senate, in writing, not less than 30 days prior to 
        contracting with a party other than the Partnership for a Drug-
        Free America.
            ``(C) Media buying contractor.--The Director shall enter 
        into a contract with a media buying contractor to plan and 
        purchase advertising time and space for the national media 
        campaign. The media buying contractor shall not provide any 
        other service or material, or conduct any other function or 
        activity which the Director determines should be provided by 
        the Partnership for a Drug-Free America.
    ``(e) Prohibitions.--None of the amounts made available under 
subsection (b) may be obligated or expended for any of the following:
        ``(1) To supplant current anti-drug community-based coalitions.
        ``(2) To supplant pro bono public service time donated by 
    national and local broadcasting networks for other public service 
    campaigns.
        ``(3) For partisan political purposes, or express advocacy in 
    support of or to defeat any clearly identified candidate, clearly 
    identified ballot initiative, or clearly identified legislative or 
    regulatory proposal.
        ``(4) To fund advertising that features any elected officials, 
    persons seeking elected office, cabinet level officials, or other 
    Federal officials employed pursuant to section 213 of Schedule C of 
    title 5, Code of Federal Regulations.
        ``(5) To fund advertising that does not contain a primary 
    message intended to reduce or prevent illicit drug use.
        ``(6) To fund advertising containing a primary message intended 
    to promote support for the media campaign or private sector 
    contributions to the media campaign.
    ``(f) Matching Requirement.--
        ``(1) In general.--Amounts made available under subsection (b) 
    for media time and space shall be matched by an equal amount of 
    non-Federal funds for the national media campaign, or be matched 
    with in-kind contributions of the same value.
        ``(2) No-cost match advertising direct relationship 
    requirement.--The Director shall ensure that at least 70 percent of 
    no-cost match advertising provided directly relates to substance 
    abuse prevention consistent with the specific purposes of the 
    national media campaign, except that in any fiscal year in which 
    less than $125,000,000 is appropriated to the national media 
    campaign, the Director shall ensure that at least 85 percent of no-
    cost match advertising directly relates to substance abuse 
    prevention consistent with the specific purposes of the national 
    media campaign.
        ``(3) No-cost match advertising not directly related.--The 
    Director shall ensure that no-cost match advertising that does not 
    directly relate to substance abuse prevention consistent with the 
    purposes of the national media campaign includes a clear anti-drug 
    message. Such message is not required to be the primary message of 
    the match advertising.
    ``(g) Financial and Performance Accountability.--The Director shall 
cause to be performed--
        ``(1) audits and reviews of costs of the national media 
    campaign pursuant to section 304C of the Federal Property and 
    Administrative Services Act of 1949 (41 U.S.C. 254d); and
        ``(2) an audit to determine whether the costs of the national 
    media campaign are allowable under section 306 of such Act (41 
    U.S.C. 256).
    ``(h) Report to Congress.--The Director shall submit on an annual 
basis a report to Congress that describes--
        ``(1) the strategy of the national media campaign and whether 
    specific objectives of the media campaign were accomplished;
        ``(2) steps taken to ensure that the national media campaign 
    operates in an effective and efficient manner consistent with the 
    overall strategy and focus of the national media campaign;
        ``(3) plans to purchase advertising time and space;
        ``(4) policies and practices implemented to ensure that Federal 
    funds are used responsibly to purchase advertising time and space 
    and eliminate the potential for waste, fraud, and abuse; and
        ``(5) all contracts entered into with a corporation, 
    partnership, or individual working on behalf of the national media 
    campaign.
    ``(i) Local Target Requirement.--The Director shall, to the maximum 
extent feasible, use amounts made available under this section for 
media that focuses on, or includes specific information on, prevention 
or treatment resources for consumers within specific local areas.
    ``(j) Prevention of Marijuana Use.--
        ``(1) Findings.--The Congress finds the following:
            ``(A) 60 percent of adolescent admissions for drug 
        treatment are based on marijuana use.
            ``(B) Potency levels of contemporary marijuana, 
        particularly hydroponically grown marijuana, are significantly 
        higher than in the past, rising from under 1 percent of THC in 
        the mid-1970s to as high as 30 percent today.
            ``(C) Contemporary research has demonstrated that youths 
        smoking marijuana early in life may be up to 5 times more 
        likely to use hard drugs.
            ``(D) Contemporary research has demonstrated clear 
        detrimental effects in adolescent educational achievement 
        resulting from marijuana use.
            ``(E) Contemporary research has demonstrated clear 
        detrimental effects in adolescent brain development resulting 
        from marijuana use.
            ``(F) An estimated 9,000,000 Americans a year drive while 
        under the influence of illegal drugs, including marijuana.
            ``(G) Marijuana smoke contains 50 to 70 percent more of 
        certain cancer causing chemicals than tobacco smoke.
            ``(H) Teens who use marijuana are up to 4 times more likely 
        to have a teen pregnancy than teens who have not.
            ``(I) Federal law enforcement agencies have identified 
        clear links suggesting that trade in hydroponic marijuana 
        facilitates trade by criminal organizations in hard drugs, 
        including heroin.
            ``(J) Federal law enforcement agencies have identified 
        possible links between trade in cannabis products and financing 
        for terrorist organizations.
        ``(2) Emphasis on prevention of youth marijuana use.--In 
    conducting advertising and activities otherwise authorized under 
    this section, the Director may emphasize prevention of youth 
    marijuana use.
    ``(k) Prevention of Methamphetamine Abuse and Other Emerging Drug 
Abuse Threats.--
        ``(1) Requirement to use 10 percent of funds for 
    methamphetamine abuse prevention.--The Director shall ensure that, 
    of the amounts appropriated under this section for the national 
    media campaign for a fiscal year, not less than 10 percent shall be 
    expended solely for the activities described in subsection (b)(1) 
    with respect to advertisements specifically intended to reduce the 
    use of methamphetamine.
        ``(2) Authority to use funds for other drug abuse upon 
    certification that methamphetamine abuse fell during fiscal year 
    2007.--With respect to fiscal year 2008 and any fiscal year 
    thereafter, if the Director certifies in writing to Congress that 
    domestic methamphetamine laboratory seizures (as reported to the El 
    Paso Intelligence Center of the Drug Enforcement Administration) 
    decreased to at least 75 percent of the 2006 level, or the Director 
    has documented a highly, statistically significant increase in a 
    specific drug, from a baseline determined by locally collected 
    data, that can be defined as a local drug crisis, the Director may 
    apply paragraph (1)(A) for that fiscal year with respect to 
    advertisements specifically intended to reduce the use of such 
    other drugs.
    ``(l) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office to carry out this section, $195,000,000 for 
each of fiscal years 2007 and 2008 and $210,000,000 for each of fiscal 
years 2009 through 2011.''.
    (b) Repeal of Superseded Provisions.--The Drug-Free Media Campaign 
Act of 1998 (21 U.S.C. 1801 et seq.) is repealed.

       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

    SEC. 601. AUTHORIZATION OF APPROPRIATIONS.
    Section 714 is amended--
        (1) by striking ``title,'' and inserting ``title except 
    activities otherwise specified,''; and
        (2) by striking ``1999 through 2003'' and inserting ``2006 
    through 2010''.
    SEC. 602. EXTENSION OF TERMINATION DATE.
    Section 715(a) is amended by striking ``September 30, 2003, this 
title and the amendments made by this title'' and inserting ``September 
30, 2010, this title and the amendments made to this title''.

                     TITLE VII--ANTI-DOPING AGENCY

    SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY.
    (a) Definitions.--In this title:
        (1) United states olympic committee.--The term ``United States 
    Olympic Committee'' means the organization established by the ``Ted 
    Stevens Olympic and Amateur Sports Act'' (36 U.S.C. 220501 et 
    seq.).
        (2) Amateur athletic competition.--The term ``amateur athletic 
    competition'' means a contest, game, meet, match, tournament, 
    regatta, or other event in which amateur athletes compete (36 
    U.S.C. 220501(b)(2)).
        (3) Amateur athlete.--The term ``amateur athlete'' means an 
    athlete who meets the eligibility standards established by the 
    national governing body or paralympic sports organization for the 
    sport in which the athlete competes (36 U.S.C. 22501(b)(1)).
        (4) Gene doping.--The term ``gene doping'' means the 
    nontherapeutic use of cells, genes, genetic elements, or of the 
    modulation of gene expression, having the capacity to enhance 
    athletic performance.
    (b) In General.--The United States Anti-Doping Agency shall--
        (1) serve as the independent anti-doping organization for the 
    amateur athletic competitions recognized by the United States 
    Olympic Committee;
        (2) ensure that athletes participating in amateur athletic 
    activities recognized by the United States Olympic Committee are 
    prevented from using performance-enhancing drugs, or performance-
    enhancing genetic modifications accomplished through gene-doping;
        (3) implement anti-doping education, research, testing, and 
    adjudication programs to prevent United States Amateur Athletes 
    participating in any activity recognized by the United States 
    Olympic Committee from using performance-enhancing drugs, or 
    performance-enhancing genetic modifications accomplished through 
    gene-doping;
        (4) serve as the United States representative responsible for 
    coordination with other anti-doping organizations coordinating 
    amateur athletic competitions recognized by the United States 
    Olympic Committee to ensure the integrity of athletic competition, 
    the health of the athletes and the prevention of use of 
    performance-enhancing drugs, or performance-enhancing genetic 
    modifications accomplished through gene-doping by United States 
    amateur athletes; and
        (5) permanently include ``gene doping'' among any list of 
    prohibited substances adopted by the Agency.
    SEC. 702. RECORDS, AUDIT, AND REPORT.
    (a) Records.--The United States Anti-Doping Agency shall keep 
correct and complete records of account.
    (b) Report.--The United States Anti-Doping Agency shall submit an 
annual report to Congress which shall include--
        (1) an audit conducted and submitted in accordance with section 
    10101 of title 36, United States Code; and
        (2) a description of the activities of the agency.
    SEC. 703. AUTHORIZATION OF APPROPRIATIONS.
    There are authorized to be appropriated to the United States Anti-
Doping Agency--
        (1) for fiscal year 2007, $9,700,000;
        (2) for fiscal year 2008, $10,300,000;
        (3) for fiscal year 2009, $10,600,000;
        (4) for fiscal year 2010, $11,000,000; and
        (5) for fiscal year 2011, $11,500,000.

                   TITLE VIII--DRUG-FREE COMMUNITIES

    SEC. 801. REAUTHORIZATION.
    (a) In General.--Section 1024(a) of the Drug-Free Communities Act 
of 1997 (21 U.S.C. 1524(a)) is amended--
        (1) in paragraph (9), by striking ``and'' after the semicolon;
        (2) in paragraph (10), by striking the period and inserting a 
    semicolon; and
        (3) by adding at the end the following:
        ``(11) $109,000,000 for fiscal year 2008;
        ``(12) $114,000,000 for fiscal year 2009;
        ``(13) $119,000,000 for fiscal year 2010;
        ``(14) $124,000,000 for fiscal year 2011; and
        ``(15) $129,000,000 for fiscal year 2012.''.
    (b) Administration Costs.--Section 1024(b) of the Drug-Free 
Communities Act of 1997 (21 U.S.C. 1524(b)) is amended to read as 
follows:
    ``(b) Administrative Costs.--
        ``(1) Limitation.--Not more than 3 percent of the funds 
    appropriated for this chapter may be used by the Office of National 
    Drug Control Policy to pay for administrative costs associated with 
    their responsibilities under the chapter.
        ``(2) Designated agency.--The agency delegated to carry out 
    this program under section 1031(d) may use up to 5 percent of the 
    funds allocated for grants under this chapter for administrative 
    costs associated with carrying out the program.''.
    SEC. 802. SUSPENSION OF GRANTS.
    (a) In General.--Section 1032(b) of the Drug-Free Communities Act 
of 1997 (21 U.S.C. 1532(b)) is amended by adding at the end the 
following:
        ``(4) Process for suspension.--A grantee shall not be suspended 
    or terminated under paragraph (1)(A)(ii), (2)(A)(iii), or (3)(E) 
    unless that grantee is afforded a fair, timely, and independent 
    appeal prior to such suspension or termination.''.
    (b) Report to Congress.--Not later than 60 days after the date of 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to Congress a report detailing the appeals 
process required by section 1032(b)(4) of the Drug-Free Communities Act 
of 1997, as added by subsection (a).
    SEC. 803. GRANT AWARD INCREASE.
    Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section 
1032 of the Drug-Free Communities Act of 1997 (21 U.S.C. 1532) are 
amended by striking ``$100,000'' and inserting ``$125,000''.
    SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRITERIA.
    Section 1032(a) of the Drug-Free Communities Act of 1997 (21 U.S.C. 
1532(a)) is amended by adding at the end the following:
        ``(7) Additional criteria.--The Director shall not impose any 
    eligibility criteria on new applicants or renewal grantees not 
    provided in this chapter.''.
    SEC. 805. NATIONAL COMMUNITY ANTI-DRUG COALITION INSTITUTE.
    Section 4 of Public Law 107-82 (21 U.S.C. 1521 note), reauthorizing 
the Drug-Free Communities Support Program, is amended--
        (1) by amending subsection (a) to read as follows:
    ``(a) In General.--The Director of the Office of National Drug 
Control Policy shall, using amounts authorized to be appropriated by 
subsection (d), make a directed grant to Community Anti-Drug Coalitions 
of America to provide for the continuation of the National Community 
Anti-drug Coalition Institute.'';
        (2) by striking subsection (b) and redesignating subsections 
    (c) and (d) as (b) and (c), respectively; and
        (3) in subsection (c), as redesignated by paragraph (2), by 
    adding at the end the following:
        ``(4) For each of the fiscal years 2008 through 2012, 
    $2,000,000.''.

              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

    SEC. 901. NATIONAL GUARD COUNTERDRUG SCHOOLS.
    (a) Authority To Operate.--Under such regulations as the Secretary 
of Defense may prescribe, the Chief of the National Guard Bureau may 
establish and operate, or provide financial assistance to the States to 
establish and operate, not more than 5 schools (to be known generally 
as ``National Guard counterdrug schools'').
    (b) Purpose.--The purpose of the National Guard counterdrug schools 
shall be the provision by the National Guard of training in drug 
interdiction and counterdrug activities and drug demand reduction 
activities to personnel of the following:
        (1) Federal agencies.
        (2) State, local, and tribal law enforcement agencies.
        (3) Community-based organizations engaged in such activities.
        (4) Other non-Federal governmental and private entities and 
    organizations engaged in such activities.
    (c) Counterdrug Schools Specified.--The National Guard counterdrug 
schools operated under the authority in subsection (a) are as follows:
        (1) The National Interagency Civil-Military Institute (NICI), 
    San Luis Obispo, California.
        (2) The Multi-Jurisdictional Counterdrug Task Force Training 
    (MCTFT), St. Petersburg, Florida.
        (3) The Midwest Counterdrug Training Center (MCTC), Johnston, 
    Iowa.
        (4) The Regional Counterdrug Training Academy (RCTA), Meridian, 
    Mississippi.
        (5) The Northeast Regional Counterdrug Training Center (NCTC), 
    Fort Indiantown Gap, Pennsylvania.
    (d) Use of National Guard Personnel.--
        (1) In general.--To the extent provided for in the State drug 
    interdiction and counterdrug activities plan of a State in which a 
    National Guard counterdrug school is located, personnel of the 
    National Guard of that State who are ordered to perform full-time 
    National Guard duty authorized under section 112(b) of that title 
    32, United States Code, may provide training referred to in 
    subsection (b) at that school.
        (2) Definition.--In this subsection, the term ``State drug 
    interdiction and counterdrug activities plan'', in the case of a 
    State, means the current plan submitted by the Governor of the 
    State to the Secretary of Defense under section 112 of title 32, 
    United States Code.
    (e) Treatment Under Authority To Provide Counterdrug Support.--The 
provisions of section 1004 of the National Defense Authorization Act 
for Fiscal Year 1991 (Public Law 101-510; 10 U.S.C. 374 note) shall 
apply to any activities of a National Guard counterdrug school under 
this section that are for an agency referred to in subsection (a) of 
such section 1004 and for a purpose set forth in subsection (b) of such 
section 1004.
    (f) Annual Reports on Activities.--
        (1) In general.--Not later than February 1 each year, the 
    Secretary of Defense shall submit to Congress a report on the 
    activities of the National Guard counterdrug schools during the 
    preceding year.
        (2) Contents.--Each report under paragraph (1) shall set forth 
    the following:
            (A) Funding.--The amount made available for each National 
        Guard counterdrug school during the fiscal year ending in the 
        year preceding the year in which such report is submitted.
            (B) Activities.--A description of the activities of each 
        National Guard counterdrug school during the year preceding the 
        year in which such report is submitted.
    (g) Authorization of Appropriations.--
        (1) In general.--There is hereby authorized to be appropriated 
    for the Department of Defense for the National Guard for each of 
    fiscal years 2006 through 2010, $30,000,000 for purposes of the 
    National Guard counterdrug schools in such fiscal year.
        (2) Construction.--The amount authorized to be appropriated by 
    paragraph (1) for a fiscal year is in addition to any other amount 
    authorized to be appropriated for the Department of Defense for the 
    National Guard for such fiscal year.

TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006

SEC. 1001. SHORT TITLE.
    This title may be cited as the ``National Methamphetamine 
Information Clearinghouse Act of 2006''.
SEC. 1002. DEFINITIONS.
    In this title--
        (1) the term ``Council'' means the National Methamphetamine 
    Advisory Council established under section 1003(b)(1);
        (2) the term ``drug endangered children'' means children whose 
    physical, mental, or emotional health are at risk because of the 
    production, use, or other effects of methamphetamine production or 
    use by another person;
        (3) the term ``National Methamphetamine Information 
    Clearinghouse'' or ``NMIC'' means the information clearinghouse 
    established under section 1003(a); and
        (4) the term ``qualified entity'' means a State, local, or 
    tribal government, school board, or public health, law enforcement, 
    nonprofit, community anti-drug coalition, or other nongovernmental 
    organization providing services related to methamphetamines.
SEC. 1003. ESTABLISHMENT OF CLEARINGHOUSE AND ADVISORY COUNCIL.
    (a) Clearinghouse.--There is established, under the supervision of 
the Attorney General of the United States, an information clearinghouse 
to be known as the National Methamphetamine Information Clearinghouse.
    (b) Advisory Council.--
        (1) In general.--There is established an advisory council to be 
    known as the National Methamphetamine Advisory Council.
        (2) Membership.--The Council shall consist of 10 members 
    appointed by the Attorney General--
            (A) not fewer than 3 of whom shall be representatives of 
        law enforcement agencies;
            (B) not fewer than 4 of whom shall be representatives of 
        nongovernmental and nonprofit organizations providing services 
        or training and implementing programs or strategies related to 
        methamphetamines; and
            (C) 1 of whom shall be a representative of the Department 
        of Health and Human Services.
        (3) Period of appointment; vacancies.--Members shall be 
    appointed for 3 years. Any vacancy in the Council shall not affect 
    its powers, but shall be filled in the same manner as the original 
    appointment.
        (4) Personnel matters.--
            (A) Travel expenses.--The members of the Council shall be 
        allowed travel expenses, including per diem in lieu of 
        subsistence, at rates authorized for employees of agencies 
        under subchapter I of chapter 57 of title 5, United States 
        Code, while away from their homes or regular places of business 
        in the performance of services for the Council.
            (B) No compensation.--The members of the Council shall not 
        receive compensation for the performance of the duties of a 
        member of the Council.
SEC. 1004. NMIC REQUIREMENTS AND REVIEW.
    (a) In General.--The NMIC shall promote sharing information 
regarding successful law enforcement, treatment, environmental, 
prevention, social services, and other programs related to the 
production, use, or effects of methamphetamine and grants available for 
such programs.
    (b) Components.--The NMIC shall include--
        (1) a toll-free number; and
        (2) a website that provides a searchable database, which--
            (A) provides information on the short-term and long-term 
        effects of methamphetamine use;
            (B) provides information regarding methamphetamine 
        treatment and prevention programs and strategies and programs 
        for drug endangered children, including descriptions of 
        successful programs and strategies and contact information for 
        such programs and strategies;
            (C) provides information regarding grants for 
        methamphetamine-related programs, including contact information 
        and links to websites;
            (D) allows a qualified entity to submit items to be posted 
        on the website regarding successful public or private programs 
        or other useful information related to the production, use, or 
        effects of methamphetamine;
            (E) includes a restricted section that may only be accessed 
        by a law enforcement organization that contains successful 
        strategies, training techniques, and other information that the 
        Council determines helpful to law enforcement agency efforts to 
        identify or combat the production, use, or effects of 
        methamphetamine;
            (F) allows public access to all information not in a 
        restricted section; and
            (G) contains any additional information the Council 
        determines may be useful in identifying or combating the 
        production, use, or effects of methamphetamine.
Thirty days after the website in paragraph (2) is operational, no funds 
shall be expended to continue the website methresources.gov.
    (c) Review of Posted Information.--
        (1) In general.--Not later than 30 days after the date of 
    submission of an item by a qualified entity, the Council shall 
    review an item submitted for posting on the website described in 
    subsection (b)(2)--
            (A) to evaluate and determine whether the item, as 
        submitted or as modified, meets the requirements for posting; 
        and
            (B) in consultation with the Attorney General, to determine 
        whether the item should be posted in a restricted section of 
        the website.
        (2) Determination.--Not later than 45 days after the date of 
    submission of an item, the Council shall--
            (A) post the item on the website described in subsection 
        (b)(2); or
            (B) notify the qualified entity that submitted the item 
        regarding the reason such item shall not be posted and 
        modifications, if any, that the qualified entity may make to 
        allow the item to be posted.
SEC. 1005. AUTHORIZATION OF APPROPRIATIONS.
    There are authorized to be appropriated--
        (1) for fiscal year 2007--
            (A) $500,000 to establish the NMIC and Council; and
            (B) such sums as are necessary for the operation of the 
        NMIC and Council; and
        (2) for each of fiscal years 2008 and 2009, such sums as are 
    necessary for the operation of the NMIC and Council.

                   TITLE XI--MISCELLANEOUS PROVISIONS

SEC. 1101. REPEALS.
    (a) Act.--Section 710 is repealed.
    (b) Forfeiture Assets.--Section 6073 of the Assets Forfeiture 
Amendments Act of 1988 (21 U.S.C. 1509) is repealed.
SEC. 1102. CONTROLLED SUBSTANCES ACT AMENDMENTS.
    Section 303(g)(2) of the Controlled Substances Act (21 U.S.C. 
823(g)(2)) is amended--
        (1) in subparagraph (B)(iii), by striking ``except that the'' 
    and inserting the following: ``unless, not sooner than 1 year after 
    the date on which the practitioner submitted the initial 
    notification, the practitioner submits a second notification to the 
    Secretary of the need and intent of the practitioner to treat up to 
    100 patients. A second notification under this clause shall contain 
    the certifications required by clauses (i) and (ii) of this 
    subparagraph. The''; and
        (2) in subparagraph (J)--
            (A) in clause (i), by striking ``thereafter'' and all that 
        follows through the period and inserting ``thereafter.'';
            (B) in clause (ii), by striking ``Drug Addiction Treatment 
        Act of 2000'' and inserting ``Office of National Drug Control 
        Policy Reauthorization Act of 2006''; and
            (C) in clause (iii), by striking ``this paragraph should 
        not remain in effect, this paragraph ceases to be in effect'' 
        and inserting ``subparagraph (B)(iii) should be applied by 
        limiting the total number of patients a practitioner may treat 
        to 30, then the provisions in such subparagraph (B)(iii) 
        permitting more than 30 patients shall not apply, effective''.
SEC. 1103. REPORT ON LAW ENFORCEMENT INTELLIGENCE SHARING.
    Not later than 180 days after the date of enactment of this Act, 
the Director shall submit to Congress a report--
        (1) evaluating existing and planned law enforcement 
    intelligence systems used by Federal, State, local, and tribal law 
    enforcement agencies responsible for drug trafficking and drug 
    production enforcement; and
        (2) addressing--
            (A) the current law enforcement intelligence systems used 
        by Federal, State, local, and tribal law enforcement agencies;
            (B) the compatibility of such systems in ensuring access 
        and availability of law enforcement intelligence to Federal, 
        State, local, and tribal law enforcement;
            (C) the extent to which Federal, State, local, and tribal 
        law enforcement are sharing law enforcement intelligence 
        information to assess current threats and design appropriate 
        enforcement strategies; and
            (D) the measures needed to ensure and to promote effective 
        information sharing among law enforcement intelligence systems 
        operated by Federal, State, local, and tribal law enforcement 
        agencies responsible for drug trafficking and drug production 
        enforcement.
SEC. 1104. REQUIREMENT FOR SOUTH AMERICAN HEROIN STRATEGY.
    (a) In General.--Not later than 90 days after the date of enactment 
of this Act, the Director, in coordination with the Secretary of State, 
shall submit to Congress a comprehensive strategy that addresses the 
increased threat from South American heroin, and in particular 
Colombian heroin, and the emerging threat from opium poppy grown in 
Peru and often intended for transit to Columbia for processing into 
heroin.
    (b) Contents.--The strategy submitted under subsection (a) shall 
include--
        (1) opium eradication efforts to eliminate the problem at the 
    source to prevent heroin from entering the stream of commerce;
        (2) interdiction and precursor chemical controls;
        (3) demand reduction and treatment;
        (4) alternative development programs, including direct 
    assistance to regional governments to demobilize and provide 
    alternative livelihoods to former members of insurgent or other 
    groups engaged in heroin, cocoa, or other illicit drug production 
    or trafficking;
        (5) efforts to inform and involve local citizens in the 
    programs described in paragraphs (1) through (4), such as through 
    leaflets advertising rewards for information; and
        (6) an assessment of the specific level of funding and 
    resources necessary to simultaneously address the threat from South 
    American heroin and the threat from Colombian and Peruvian coca.
    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy submitted under subsection 
(a) that involves information classified under criteria established by 
an Executive order, or whose public disclosure, as determined by the 
Director or the head of any relevant Federal agency, would be 
detrimental to the law enforcement of national security activities of 
any Federal, foreign, or international agency, shall be presented to 
Congress separately from the rest of the strategy.
SEC. 1105. MODEL ACTS.
    (a) In General.--The Director of the Office of National Drug 
Control Policy shall provide for or shall enter into an agreement with 
a non-profit corporation that is described in section 501(c)(3) of the 
Internal Revenue Code of 1986 and exempt from tax under section 501(a) 
of such Code to--
        (1) advise States on establishing laws and policies to address 
    alcohol and other drug issues, based on the model State drug laws 
    developed by the President's Commission on Model State Drug Laws in 
    1993; and
        (2) revise such model State drug laws and draft supplementary 
    model State laws to take into consideration changes in the alcohol 
    and drug abuse problems in the State involved.
    (b) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this subsection $1,500,000 for each of fiscal 
years 2007 through 2011.
SEC. 1106. STUDY ON IATROGENIC ADDICTION ASSOCIATED WITH PRESCRIPTION 
OPIOID ANALGESIC DRUGS.
    (a) In General.--
        (1) Study.--The Director of the Office of National Drug Control 
    Policy shall request the Institute of Medicine of the National 
    Academy of Sciences to enter into an agreement under which the 
    Institute agrees to study certain aspects of iatrogenic addiction 
    to prescription opioid analgesics included in schedules II and III 
    of the Controlled Substances Act (21 U.S.C. 812).
        (2) Iatrogenic addiction.--In this section, the term 
    ``iatrogenic addiction'' means an addiction developed from the use 
    of an opioid analgesic by an individual with no previous history of 
    any addiction, who has lawfully obtained and used the drug for a 
    legitimate medical purpose by administration from, or pursuant to 
    the prescription or order of, an individual practitioner acting in 
    the usual course of professional practice.
    (b) Requirements.--The study conducted pursuant to this section 
shall assess the current scientific literature to determine, if 
possible--
        (1) the rate of iatrogenic addiction associated with the 
    appropriate use of prescription drugs described in subsection (a);
        (2) the impact of iatrogenic addiction associated with the 
    appropriate use of prescription drugs described in subsection (a) 
    on the individual, the prescriber, other patients, and society in 
    general;
        (3) the comparative abuse liability of prescription drugs 
    described in subsection (a) when used properly by the ultimate user 
    for a legitimate medical purpose; and
        (4)(A) what types of prospective or retrospective studies 
    should be undertaken to determine the rate of iatrogenic addiction 
    associated with the appropriate use of the prescription drugs 
    described in subsection (a); and
        (B) a feasible timeline for conducting and reporting such 
    studies, should the current state of the scientific literature be 
    insufficient to determine the rate, impact, and comparative abuse 
    liability of prescription drugs described in subsection (a).
    (c) Report.--Not later than 1 year after the date of enactment of 
this Act, the Director of the Office of National Drug Control Policy 
shall ensure that the agreement under subsection (a) provides for the 
submission of a report to the Congress on the status of the study 
conducted pursuant to this section.
SEC. 1107. REQUIREMENT FOR STRATEGY TO STOP INTERNET ADVERTISING OF 
PRESCRIPTION MEDICINES WITHOUT A PRESCRIPTION.
    Not later than 120 days after the date of the enactment of this 
Act, the Director of the Office of National Drug Control Policy shall 
submit to Congress a strategy to stop advertisements that provide 
information about obtaining over the Internet drugs (as defined in 
section 702(3) of the Office of National Drug Control Policy 
Reauthorization Act of 1998) for which a prescription is required 
without the use of such a lawful prescription.
SEC. 1108. REQUIREMENT FOR STUDY ON DIVERSION AND INAPPROPRIATE USES OF 
PRESCRIPTION DRUGS.
    Not later than 90 days after the date of enactment of this Act, the 
Director of the Office of National Drug Control Policy, in consultation 
with the Secretary of Health and Human Services, shall submit to 
Congress a report that includes a plan to conduct a study on the 
illegal diversion and inappropriate uses of prescription drugs, 
including the following:
        (1) Methods to utilize both public use surveys that are in 
    existence as of the date of enactment of this Act and other surveys 
    to provide appropriate baseline data on the natural history of 
    diversion and abuse of prescription drugs that are included in 
    schedules under the Controlled Substances Act to evaluate the 
    extent and nature of potential problems with such use to guide 
    corrective actions which may reduce such problems without 
    unintentionally hindering access to these drugs for legitimate 
    medical purposes. Specifically, other surveys to be considered are 
    those that address the abuse of these substances on a regional or 
    national basis, and those that address the diversion of these 
    substances on a regional or national basis.
        (2) A scientifically based analysis of the relative 
    contribution of both innate and acquired genetic factors, 
    environmental factors, psychological factors, and drug 
    characteristics that contribute to addiction to prescription drugs.
SEC. 1109. REQUIREMENT FOR AFGHAN HEROIN STRATEGY.
    (a) In General.--Not later than 90 days after the date of the 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to the Congress a comprehensive strategy 
that addresses the increased threat from Afghan heroin.
    (b) Contents.--The strategy shall include--
        (1) opium crop eradication efforts to eliminate the problem at 
    the source to prevent heroin from entering the stream of commerce;
        (2) destruction or other direct elimination of stockpiles of 
    heroin and raw opium, and heroin production and storage facilities;
        (3) interdiction and precursor chemical controls;
        (4) demand reduction and treatment;
        (5) alternative development programs;
        (6) measures to improve cooperation and coordination between 
    Federal Government agencies, and between such agencies, agencies of 
    foreign governments, and international organizations with 
    responsibility for the prevention of heroin production in, or 
    trafficking out of, Afghanistan; and
        (7) an assessment of the specific level of funding and 
    resources necessary to significantly reduce the production and 
    trafficking of heroin.
    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy that involves information 
classified under criteria established by an Executive order, or whose 
public disclosure, as determined by the Director or the head of any 
relevant Federal agency, would be detrimental to the law enforcement or 
national security activities of any Federal, foreign, or international 
agency, shall be presented to Congress separately from the rest of the 
strategy.
SEC. 1110. REQUIREMENT FOR SOUTHWEST BORDER COUNTERNARCOTICS STRATEGY.
    (a) In General.--Not later than 120 days after the date of 
enactment of this Act, and every 2 years thereafter, the Director of 
National Drug Control Policy shall submit to the Congress a Southwest 
Border Counternarcotics Strategy.
    (b) Purposes.--The Southwest Border Counternarcotics Strategy 
shall--
        (1) set forth the Government's strategy for preventing the 
    illegal trafficking of drugs across the international border 
    between the United States and Mexico, including through ports of 
    entry and between ports of entry on that border;
        (2) state the specific roles and responsibilities of the 
    relevant National Drug Control Program agencies (as defined in 
    section 702 of the Office of National Drug Control Policy 
    Reauthorization Act of 1998 (21 U.S.C. 1701)) for implementing that 
    strategy; and
        (3) identify the specific resources required to enable the 
    relevant National Drug Control Program agencies to implement that 
    strategy.
    (c) Specific Content Related to Drug Tunnels Between the United 
States and Mexico.--The Southwest Border Counternarcotics Strategy 
shall include--
        (1) a strategy to end the construction and use of tunnels and 
    subterranean passages that cross the international border between 
    the United States and Mexico for the purpose of illegal trafficking 
    of drugs across such border; and
        (2) recommendations for criminal penalties for persons who 
    construct or use such a tunnel or subterranean passage for such a 
    purpose.
    (d) Consultation With Other Agencies.--The Director shall issue the 
Southwest Border Counternarcotics Strategy in consultation with the 
heads of the relevant National Drug Control Program agencies.
    (e) Limitation.--The Southwest Border Counternarcotics Strategy 
shall not change existing agency authorities or the laws governing 
interagency relationships, but may include recommendations about 
changes to such authorities or laws.
    (f) Report to Congress.--The Director shall provide a copy of the 
Southwest Border Counternarcotics Strategy to the appropriate 
congressional committees (as defined in section 702 of the Office of 
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1701)), and to the Committee on Armed Services and the Committee on 
Homeland Security of the House of Representatives, and the Committee on 
Homeland Security and Governmental Affairs and the Committee on Armed 
Services of the Senate.
    (g) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the Southwest Border Counternarcotics 
Strategy that involves information classified under criteria 
established by an Executive order, or whose public disclosure, as 
determined by the Director or the head of any relevant National Drug 
Control Program agency, would be detrimental to the law enforcement or 
national security activities of any Federal, State, local, or tribal 
agency, shall be presented to Congress separately from the rest of the 
strategy.
SEC. 1111. REQUIREMENT FOR SCIENTIFIC STUDY OF MYCOHERBICIDE IN ILLICIT 
DRUG CROP ERADICATION.
    (a) Requirement.--Not later than 90 days after the date of 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to the Congress a report that includes a 
plan to conduct, on an expedited basis, a scientific study of the use 
of mycoherbicide as a means of illicit drug crop elimination by an 
appropriate Government scientific research entity, including a complete 
and thorough scientific peer review. The study shall include an 
evaluation of the likely human health and environmental impacts of 
mycoherbicides derived from fungus naturally existing in the soil.
    (b) Study.--The study required by this section shall be conducted 
in United States territory and not in any foreign country.
SEC. 1112. REQUIREMENT FOR STUDY OF STATE PRECURSOR CHEMICAL CONTROL 
LAWS.
    (a) Study.--The Director of National Drug Control Policy, in 
consultation with the National Alliance for Model State Drug Laws, 
shall conduct a study of State laws with respect to precursor chemical 
controls.
    (b) Report.--Not later than 6 months after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit a report to Congress on the results of the study under 
subsection (a), including--
        (1) a comparison of the State laws studied and the 
    effectiveness of each such law; and
        (2) a list of best practices observed with respect to such 
    laws.
SEC. 1113. REQUIREMENT FOR STUDY OF DRUG ENDANGERED CHILDREN PROGRAMS.
    (a) Study.--The Director of National Drug Control Policy shall 
conduct a study of methamphetamine-related activities that are 
conducted by different Drug Endangered Children programs administered 
by States.
    (b) Report.--Not later than 6 months after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress a report on the results of the study under 
subsection (a). Such report shall include--
        (1) an analysis of the best practices of the activities 
    studied; and
        (2) recommendations for establishing a national policy to 
    address drug endangered children, based on the Drug Endangered 
    Children programs administered by States.
    (c) Definitions.--In this section--
        (1) the term ``methamphetamine-related activity'' means any 
    activity related to the production, use, or effects of 
    methamphetamine; and
        (2) the term ``drug endangered children'' means children whose 
    physical, mental, or emotional health are at risk because of the 
    production, use, or effects of methamphetamine by another person.
SEC. 1114. STUDY ON DRUG COURT HEARINGS IN NONTRADITIONAL PLACES.
    (a) Finding.--Congress finds that encouraging drug courts and 
schools to enter into partnerships that allow students to see the 
repercussions of drug abuse by non-violent offenders may serve as a 
strong deterrent and promote demand reduction.
    (b) Study.--The Director of the Office of National Drug Control 
Policy shall conduct a study on drug court programs that conduct 
hearings in nontraditional public places, such as schools. At a 
minimum, the study shall evaluate similar programs in operation, such 
as the program operated in the Fourth Judicial District Drug Court, in 
Washington County, Arkansas.
    (c) Requirement.--At the same time the President submits to 
Congress the National Drug Control Strategy due February 1, 2007, 
pursuant to section 706 of the Office of National Drug Control Policy 
Reauthorization Act of 1998, the President shall submit to Congress a 
report on the study conducted under subsection (b). The report shall 
include an evaluation of the results of the study and such 
recommendations as the President considers appropriate.
    (d) Demand Reduction.--In this section, the term ``demand 
reduction'' has the meaning provided in section 702(1) of the Office of 
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1701(1)).
SEC. 1115. REPORT ON TRIBAL GOVERNMENT PARTICIPATION IN HIDTA PROCESS.
    (a) Report Requirement.--The Director of the Office of National 
Drug Control Policy shall prepare a report for Congress on the 
representation of tribal governments in the High Intensity Drug 
Trafficking Areas Program and in high intensity drug trafficking areas 
designated under that Program. The report shall include--
        (1) a list of the tribal governments represented in the Program 
    and a description of the participation by such governments in the 
    Program;
        (2) an explanation of the rationale for the level of 
    representation by such governments; and
        (3) recommendations by the Director for methods for increasing 
    the number of tribal governments represented in the Program.
    (b) Deadline.--The report prepared under subsection (a) shall be 
submitted not later than 1 year after the date of the enactment of this 
Act.
    (c) Definition.--In this section, the term ``High Intensity Drug 
Trafficking Areas Program'' means the program established under section 
707 of the Office of National Drug Control Policy Reauthorization Act 
of 1998 (21 U.S.C. 1706)
SEC. 1116. REPORT ON SCHOOL DRUG TESTING.
    (a) Report Requirement.--The Director of National Drug Control 
Policy shall prepare a report on drug testing in schools. The report 
shall include a list of secondary schools that have initiated drug 
testing from among those schools that have attended conferences on drug 
testing sponsored by the Office of National Drug Control Policy.
    (b) Deadline.--Not later than 120 days after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress the report required under subsection (a).
SEC. 1117. REPORT ON ONDCP PERFORMANCE BONUSES.
    (a) Report Requirement.--The Director of National Drug Control 
Policy shall prepare a report on performance bonuses at the Office of 
National Drug Control Policy. The report shall include a list of 
employees who received performance bonuses, and the amount of such 
bonuses, for the period beginning on October 1, 2004, and ending on the 
date of submission of the report.
    (b) Deadline.--Not later than 120 days after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress the report required under subsection (a).
SEC. 1118. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF ALL 
FEDERAL ADVERTISING OR OTHER COMMUNICATION MATERIALS.
    Section 712 is amended to read as follows:
    ``SEC. 712. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF 
      ALL FEDERAL ADVERTISING OR OTHER COMMUNICATION MATERIALS.
    ``(a) Requirement.--Each advertisement or other communication paid 
for by the Office, either directly or through a contract awarded by the 
Office, shall include a prominent notice informing the target audience 
that the advertisement or other communication is paid for by the 
Office.
    ``(b) Advertisement or Other Communication.--In this section, the 
term `advertisement or other communication' includes--
        ``(1) an advertisement disseminated in any form, including 
    print or by any electronic means; and
        ``(2) a communication by an individual in any form, including 
    speech, print, or by any electronic means.''.
SEC. 1119. AWARDS FOR DEMONSTRATION PROGRAMS BY LOCAL PARTNERSHIPS TO 
COERCE ABSTINENCE IN CHRONIC HARD-DRUG USERS UNDER COMMUNITY 
SUPERVISION THROUGH THE USE OF DRUG TESTING AND SANCTIONS.
    At the end of the Act, insert the following:
    ``SEC. 716. AWARDS FOR DEMONSTRATION PROGRAMS BY LOCAL PARTNERSHIPS 
      TO COERCE ABSTINENCE IN CHRONIC HARD-DRUG USERS UNDER COMMUNITY 
      SUPERVISION THROUGH THE USE OF DRUG TESTING AND SANCTIONS.
    ``(a) Awards Required.--The Director shall make competitive awards 
to fund demonstration programs by eligible partnerships for the purpose 
of reducing the use of illicit drugs by chronic hard-drug users living 
in the community while under the supervision of the criminal justice 
system.
    ``(b) Use of Award Amounts.--Award amounts received under this 
section shall be used--
        ``(1) to support the efforts of the agencies, organizations, 
    and researchers included in the eligible partnership;
        ``(2) to develop and field a drug testing and graduated 
    sanctions program for chronic hard-drug users living in the 
    community under criminal justice supervision; and
        ``(3) to assist individuals described in subsection (a) by 
    strengthening rehabilitation efforts through such means as job 
    training, drug treatment, or other services.
    ``(c) Eligible Partnership Defined.--In this section, the term 
`eligible partnership' means a working group whose application to the 
Director--
        ``(1) identifies the roles played, and certifies the 
    involvement of, two or more agencies or organizations, which may 
    include--
            ``(A) State, local, or tribal agencies (such as those 
        carrying out police, probation, prosecution, courts, 
        corrections, parole, or treatment functions);
            ``(B) Federal agencies (such as the Drug Enforcement 
        Agency, the Bureau of Alcohol, Tobacco, Firearms, and 
        Explosives, and United States Attorney offices); and
            ``(C) community-based organizations;
        ``(2) includes a qualified researcher;
        ``(3) includes a plan for using judicial or other criminal 
    justice authority to administer drug tests to individuals described 
    in subsection (a) at least twice a week, and to swiftly and 
    certainly impose a known set of graduated sanctions for non-
    compliance with community-release provisions relating to drug 
    abstinence (whether imposed as a pre-trial, probation, or parole 
    condition or otherwise);
        ``(4) includes a strategy for responding to a range of 
    substance use and abuse problems and a range of criminal histories;
        ``(5) includes a plan for integrating data infrastructure among 
    the agencies and organizations included in the eligible partnership 
    to enable seamless, real-time tracking of individuals described in 
    subsection (a);
        ``(6) includes a plan to monitor and measure the progress 
    toward reducing the percentage of the population of individuals 
    described in subsection (a) who, upon being summoned for a drug 
    test, either fail to show up or who test positive for drugs.
    ``(d) Reports to Congress.--
        ``(1) Interim report.--Not later than June 1, 2009, the 
    Director shall submit to Congress a report that identifies the best 
    practices in reducing the use of illicit drugs by chronic hard-drug 
    users, including the best practices identified through the 
    activities funded under this section.
        ``(2) Final report.--Not later than June 1, 2010, the Director 
    shall submit to Congress a report on the demonstration programs 
    funded under this section, including on the matters specified in 
    paragraph (1).
    ``(e) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section $4,900,000 for each of fiscal 
years 2007 through 2009.''.
SEC. 1120. POLICY RELATING TO SYRINGE EXCHANGE PROGRAMS.
    Section 703(a) (21 U.S.C. 1702(a)) is amended by adding at the end 
the following:
``When developing the national drug control policy, any policy of the 
Director relating to syringe exchange programs for intravenous drug 
users shall be based on the best available medical and scientific 
evidence regarding their effectiveness in promoting individual health 
and preventing the spread of infectious disease, and their impact on 
drug addiction and use. In making any policy relating to syringe 
exchange programs, the Director shall consult with the National 
Institutes of Health and the National Academy of Sciences.''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.